false Q3 --09-30 0001961847 http://fasb.org/us-gaap/2025#UsefulLifeTermOfLeaseMember 0001961847 2024-10-01 2025-06-30 0001961847 2025-06-30 0001961847 2024-09-30 0001961847 2024-10-09 2024-10-09 0001961847 2025-04-01 2025-06-30 0001961847 2024-04-01 2024-06-30 0001961847 2023-10-01 2024-06-30 0001961847 us-gaap:ProductMember 2025-04-01 2025-06-30 0001961847 us-gaap:ProductMember 2024-04-01 2024-06-30 0001961847 us-gaap:ProductMember 2024-10-01 2025-06-30 0001961847 us-gaap:ProductMember 2023-10-01 2024-06-30 0001961847 us-gaap:CommonStockMember 2023-09-30 0001961847 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001961847 us-gaap:RetainedEarningsMember 2023-09-30 0001961847 us-gaap:NoncontrollingInterestMember 2023-09-30 0001961847 INHD:SubscriptionReceivableMember 2023-09-30 0001961847 2023-09-30 0001961847 us-gaap:CommonStockMember 2023-12-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001961847 us-gaap:RetainedEarningsMember 2023-12-31 0001961847 us-gaap:NoncontrollingInterestMember 2023-12-31 0001961847 INHD:SubscriptionReceivableMember 2023-12-31 0001961847 2023-12-31 0001961847 us-gaap:CommonStockMember 2024-03-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001961847 us-gaap:RetainedEarningsMember 2024-03-31 0001961847 us-gaap:NoncontrollingInterestMember 2024-03-31 0001961847 INHD:SubscriptionReceivableMember 2024-03-31 0001961847 2024-03-31 0001961847 us-gaap:CommonStockMember 2024-09-30 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001961847 us-gaap:RetainedEarningsMember 2024-09-30 0001961847 us-gaap:NoncontrollingInterestMember 2024-09-30 0001961847 INHD:SubscriptionReceivableMember 2024-09-30 0001961847 us-gaap:CommonStockMember 2024-12-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001961847 us-gaap:RetainedEarningsMember 2024-12-31 0001961847 us-gaap:NoncontrollingInterestMember 2024-12-31 0001961847 INHD:SubscriptionReceivableMember 2024-12-31 0001961847 2024-12-31 0001961847 us-gaap:CommonStockMember 2025-03-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001961847 us-gaap:RetainedEarningsMember 2025-03-31 0001961847 us-gaap:NoncontrollingInterestMember 2025-03-31 0001961847 INHD:SubscriptionReceivableMember 2025-03-31 0001961847 2025-03-31 0001961847 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001961847 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001961847 us-gaap:NoncontrollingInterestMember 2023-10-01 2023-12-31 0001961847 INHD:SubscriptionReceivableMember 2023-10-01 2023-12-31 0001961847 2023-10-01 2023-12-31 0001961847 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001961847 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001961847 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001961847 INHD:SubscriptionReceivableMember 2024-01-01 2024-03-31 0001961847 2024-01-01 2024-03-31 0001961847 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001961847 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001961847 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001961847 INHD:SubscriptionReceivableMember 2024-04-01 2024-06-30 0001961847 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001961847 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001961847 us-gaap:NoncontrollingInterestMember 2024-10-01 2024-12-31 0001961847 INHD:SubscriptionReceivableMember 2024-10-01 2024-12-31 0001961847 2024-10-01 2024-12-31 0001961847 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001961847 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001961847 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001961847 INHD:SubscriptionReceivableMember 2025-01-01 2025-03-31 0001961847 2025-01-01 2025-03-31 0001961847 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001961847 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001961847 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001961847 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0001961847 INHD:SubscriptionReceivableMember 2025-04-01 2025-06-30 0001961847 us-gaap:CommonStockMember 2024-06-30 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001961847 us-gaap:RetainedEarningsMember 2024-06-30 0001961847 us-gaap:NoncontrollingInterestMember 2024-06-30 0001961847 INHD:SubscriptionReceivableMember 2024-06-30 0001961847 2024-06-30 0001961847 us-gaap:CommonStockMember 2025-06-30 0001961847 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001961847 us-gaap:RetainedEarningsMember 2025-06-30 0001961847 us-gaap:NoncontrollingInterestMember 2025-06-30 0001961847 INHD:SubscriptionReceivableMember 2025-06-30 0001961847 INHD:CastorBuildingTechLLCMember 2022-01-18 0001961847 INHD:CastorBuildingTechLLCMember INHD:NewOwnershipAgreementMember 2023-10-16 0001961847 INHD:InnoMetalStudsCorpMember 2022-01-21 0001961847 INHD:MrDekuiLiuMember 2022-01-21 2022-01-21 0001961847 INHD:MrDekuiLiuMember INHD:InnoMetalStudsCorpMember 2022-01-21 0001961847 INHD:InnoResearchInstituteLLCMember INHD:InnoMetalStudsCorpMember 2021-09-08 0001961847 2024-01-27 2024-01-27 0001961847 INHD:LearGroupLimitedMember 2024-10-18 2024-10-18 0001961847 INHD:BaymaxHighTechnologyCoLimitedMember 2024-12-13 2024-12-13 0001961847 INHD:ArchitectixLimitedMember 2025-03-04 2025-03-04 0001961847 INHD:CastorBuildingTechLLCMember INHD:NewOwnershipAgreementMember 2025-03-28 0001961847 INHD:StrucraftGroupLimitedMember 2025-03-28 2025-03-28 0001961847 INHD:StrucraftGroupLimitedMember 2025-04-08 2025-04-08 0001961847 us-gaap:MachineryAndEquipmentMember 2025-06-30 0001961847 us-gaap:OfficeEquipmentMember 2025-06-30 0001961847 us-gaap:VehiclesMember 2025-06-30 0001961847 us-gaap:LeaseholdImprovementsMember 2025-06-30 0001961847 INHD:CoreModuLLCMember 2025-03-28 2025-03-28 0001961847 INHD:StrucraftGroupLimitedMember 2025-06-30 0001961847 INHD:HSTTradingLimitedMember 2025-02-28 0001961847 INHD:HSTTradingLimitedMember INHD:LoanAgreementMember 2025-02-28 0001961847 INHD:CoreModuLLCMember 2024-10-14 0001961847 INHD:CoreModuLLCMember 2025-03-28 0001961847 INHD:CoreModuLLCMember 2025-03-28 2025-03-28 0001961847 INHD:AuroraTechnologyHoldingLimitedMember 2025-05-28 0001961847 2024-12-13 2024-12-13 0001961847 INHD:AuroraTechnologyHoldingLimitedMember 2025-06-30 0001961847 INHD:ThreeIndividualsMember 2023-06-01 2023-08-31 0001961847 INHD:IndividualsMember 2025-06-30 0001961847 INHD:IndividualsMember 2024-09-30 0001961847 INHD:IMSCATAndCBTMember 2025-06-30 0001961847 INHD:IMSCATAndCBTMember 2024-09-30 0001961847 INHD:IMSCATAndCBTMember 2025-04-01 2025-06-30 0001961847 INHD:IMSCATAndCBTMember 2024-04-01 2024-06-30 0001961847 INHD:IMSCATAndCBTMember 2024-10-01 2025-06-30 0001961847 INHD:IMSCATAndCBTMember 2023-10-01 2024-06-30 0001961847 INHD:MrDekuiLiuMember 2025-06-30 0001961847 INHD:MrDekuiLiuMember 2024-09-30 0001961847 INHD:WiseHillIncMember 2025-06-30 0001961847 INHD:ZfounderOrganizationIncMember 2025-06-30 0001961847 INHD:WiseHillIncMember 2024-09-30 0001961847 INHD:ZfounderOrganizationIncMember 2024-09-30 0001961847 INHD:ZfounderOrganizationIncMember 2025-04-01 2025-06-30 0001961847 INHD:ZfounderOrganizationIncMember 2024-10-01 2025-06-30 0001961847 INHD:VisionOpportunityFundLPMember 2023-03-01 2023-03-31 0001961847 INHD:VisionOpportunityFundLPMember 2025-06-30 0001961847 INHD:VisionOpportunityFundLPMember 2024-10-01 2025-06-30 0001961847 INHD:CoreModuLLCMember 2025-04-01 2025-06-30 0001961847 INHD:CoreModuLLCMember 2024-10-01 2025-06-30 0001961847 INHD:BaichengTradingLLCMember 2025-06-30 0001961847 INHD:BaichengTradingLLCMember 2024-09-30 0001961847 INHD:AuroraTechnologyHoldingLimitedMember 2025-06-30 0001961847 2021-09-08 0001961847 us-gaap:CommonStockMember 2022-11-30 2022-11-30 0001961847 2023-07-23 0001961847 2023-07-24 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2022-12-01 2022-12-31 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2022-12-31 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2023-02-01 2023-02-28 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2023-02-28 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2023-03-01 2023-03-31 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2023-03-31 0001961847 srt:ChiefFinancialOfficerMember 2023-06-20 2023-06-20 0001961847 INHD:OneNonemployeeContractorMember 2023-06-20 2023-06-20 0001961847 2023-06-20 0001961847 INHD:OneNonemployeeContractorMember 2024-01-01 2024-01-01 0001961847 us-gaap:IPOMember 2023-12-18 0001961847 us-gaap:IPOMember 2023-12-18 2023-12-18 0001961847 srt:MaximumMember 2024-12-18 0001961847 2024-12-18 0001961847 2023-12-18 0001961847 INHD:WarrantAssumptionAgreementMember 2024-03-01 0001961847 INHD:WarrantAssumptionAgreementMember 2024-03-01 2024-03-01 0001961847 INHD:WarrantAssumptionAgreementMember 2024-09-30 0001961847 2023-12-14 2023-12-14 0001961847 2023-12-19 2023-12-19 0001961847 us-gaap:InvestorMember 2024-10-31 2024-10-31 0001961847 us-gaap:InvestorMember 2024-10-31 0001961847 INHD:NineNonUSInvestorMember 2024-11-13 2024-11-13 0001961847 INHD:NineNonUSInvestorMember 2024-11-13 0001961847 INHD:NineNonUSInvestorMember 2024-12-11 2024-12-11 0001961847 INHD:NineNonUSInvestorMember 2024-12-11 0001961847 srt:ChiefExecutiveOfficerMember 2025-01-16 2025-01-16 0001961847 srt:ChiefFinancialOfficerMember 2025-01-16 2025-01-16 0001961847 INHD:EmployeeMember 2025-05-28 2025-05-28 0001961847 us-gaap:InvestorMember 2025-06-02 2025-06-02 0001961847 us-gaap:InvestorMember 2025-06-02 0001961847 us-gaap:CommonStockMember 2025-01-27 2025-01-27 0001961847 us-gaap:CommonStockMember 2025-01-27 0001961847 srt:MaximumMember 2025-06-30 0001961847 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember INHD:TwoCustomersMember 2025-04-01 2025-06-30 0001961847 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember INHD:TwoCustomersMember 2024-10-01 2025-06-30 0001961847 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember INHD:ThreeCustomersMember 2025-04-01 2025-06-30 0001961847 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember INHD:ThreeCustomersMember 2024-10-01 2025-06-30 0001961847 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember INHD:TwoSuppliersMember 2025-04-01 2025-06-30 0001961847 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember INHD:TwoSuppliersMember 2024-10-01 2025-06-30 0001961847 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember INHD:TwoSuppliersMember 2024-04-01 2024-06-30 0001961847 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember INHD:TwoSuppliersMember 2023-10-01 2024-06-30 0001961847 us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember INHD:TwoSuppliersMember 2023-10-01 2024-09-30 0001961847 2024-07-23 2024-07-23 0001961847 2024-12-01 2024-12-31 0001961847 country:HK 2025-04-01 2025-06-30 0001961847 country:HK 2024-04-01 2024-06-30 0001961847 country:HK 2024-10-01 2025-06-30 0001961847 country:HK 2023-10-01 2024-06-30 0001961847 us-gaap:RestrictedStockMember 2025-04-01 2025-06-30 0001961847 us-gaap:RestrictedStockMember 2024-04-01 2024-06-30 0001961847 us-gaap:RestrictedStockMember 2024-10-01 2025-06-30 0001961847 us-gaap:RestrictedStockMember 2023-10-01 2024-06-30 0001961847 2025-01-16 0001961847 2025-05-28 0001961847 2025-06-30 2025-06-30 0001961847 us-gaap:SubsequentEventMember 2025-07-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft utr:acre

false Q1 --09-30 2026 0001961847 http://fasb.org/us-gaap/2025#UsefulLifeTermOfLeaseMember 0001961847 2025-10-01 2025-12-31 0001961847 2026-01-30 0001961847 2025-12-31 0001961847 2025-09-30 0001961847 2025-12-22 2025-12-22 0001961847 2024-10-01 2024-12-31 0001961847 us-gaap:ProductMember 2025-10-01 2025-12-31 0001961847 us-gaap:ProductMember 2024-10-01 2024-12-31 0001961847 us-gaap:CommonStockMember 2024-09-30 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001961847 us-gaap:RetainedEarningsMember 2024-09-30 0001961847 us-gaap:NoncontrollingInterestMember 2024-09-30 0001961847 2024-09-30 0001961847 us-gaap:CommonStockMember 2025-09-30 0001961847 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001961847 us-gaap:RetainedEarningsMember 2025-09-30 0001961847 us-gaap:NoncontrollingInterestMember 2025-09-30 0001961847 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001961847 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001961847 us-gaap:NoncontrollingInterestMember 2024-10-01 2024-12-31 0001961847 us-gaap:CommonStockMember 2025-10-01 2025-12-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2025-10-01 2025-12-31 0001961847 us-gaap:RetainedEarningsMember 2025-10-01 2025-12-31 0001961847 us-gaap:NoncontrollingInterestMember 2025-10-01 2025-12-31 0001961847 us-gaap:CommonStockMember 2024-12-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001961847 us-gaap:RetainedEarningsMember 2024-12-31 0001961847 us-gaap:NoncontrollingInterestMember 2024-12-31 0001961847 2024-12-31 0001961847 us-gaap:CommonStockMember 2025-12-31 0001961847 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001961847 us-gaap:RetainedEarningsMember 2025-12-31 0001961847 us-gaap:NoncontrollingInterestMember 2025-12-31 0001961847 INHD:CastorBuildingTechLLCMember 2022-01-18 0001961847 INHD:CastorBuildingTechLLCMember INHD:NewOwnershipAgreementMember 2023-10-16 0001961847 INHD:InnoMetalStudsCorpMember 2022-01-21 0001961847 INHD:MrDekuiLiuMember 2022-01-21 2022-01-21 0001961847 INHD:MrDekuiLiuMember INHD:InnoMetalStudsCorpMember 2022-01-21 0001961847 INHD:InnoResearchInstituteLLCMember INHD:InnoMetalStudsCorpMember 2021-09-08 0001961847 2024-01-27 2024-01-27 0001961847 INHD:LearGroupLimitedMember 2024-10-18 2024-10-18 0001961847 INHD:BaymaxHighTechnologyCoLimitedMember 2024-12-13 2024-12-13 0001961847 INHD:ArchitectixLimitedMember 2025-03-04 2025-03-04 0001961847 INHD:CastorBuildingTechLLCMember INHD:NewOwnershipAgreementMember 2025-03-28 0001961847 INHD:StrucraftGroupLimitedMember 2025-03-28 2025-03-28 0001961847 INHD:StrucraftGroupLimitedMember 2025-04-08 2025-04-08 0001961847 us-gaap:EquityUnitPurchaseAgreementsMember 2025-07-04 0001961847 INHD:StandbyEquityPurchaseAgreementMember 2025-07-04 2025-07-04 0001961847 INHD:StandbyEquityPurchaseAgreementMember 2025-07-04 2025-07-04 0001961847 INHD:StandbyEquityPurchaseAgreementMember 2025-12-31 0001961847 INHD:StandbyEquityPurchaseAgreementMember 2025-06-30 0001961847 INHD:StandbyEquityPurchaseAgreementMember 2025-10-01 2025-12-31 0001961847 us-gaap:MachineryAndEquipmentMember 2025-12-31 0001961847 us-gaap:OfficeEquipmentMember 2025-12-31 0001961847 us-gaap:VehiclesMember 2025-12-31 0001961847 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001961847 INHD:HSTTradingLimitedMember 2025-02-28 0001961847 INHD:HSTTradingLimitedMember INHD:LoanAgreementMember 2025-02-28 0001961847 INHD:HSTTradingLimitedMember 2025-08-07 0001961847 INHD:HSTTradingLimitedMember INHD:LoanAgreementMember 2025-08-07 0001961847 INHD:TorchlightGroupLimitedMember 2025-10-02 0001961847 INHD:TorchlightGroupLimitedMember INHD:LoanAgreementMember 2025-10-02 0001961847 INHD:TorchlightGroupLimitedMember 2025-12-31 0001961847 INHD:ShengshiChuangtouCoLimitedMember 2025-12-01 0001961847 INHD:ShengshiChuangtouCoLimitedMember INHD:LoanAgreementMember 2025-12-01 0001961847 INHD:ShengshiChuangtouCoLimitedMember 2025-12-31 0001961847 INHD:CoreModuLLCMember 2024-10-14 0001961847 INHD:CoreModuLLCMember 2025-03-28 0001961847 INHD:CoreModuLLCMember 2025-03-28 2025-03-28 0001961847 INHD:AuroraTechnologyHoldingLimitedMember 2025-05-28 0001961847 INHD:LearGroupLimitedMember 2025-08-06 0001961847 2024-12-13 2024-12-13 0001961847 2023-06-01 2023-08-31 0001961847 us-gaap:EquityUnitPurchaseAgreementsMember 2025-07-04 2025-07-04 0001961847 INHD:StandbyEquityPurchaseAgreementMember 2025-09-30 2025-09-30 0001961847 INHD:StandbyEquityPurchaseAgreementMember 2025-09-30 0001961847 INHD:MeasurementInputExpectedProbablyOfDrawsMember 2025-12-31 0001961847 INHD:MeasurementInputExpectedProbablyOfDrawsMember 2025-09-30 0001961847 us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-12-31 0001961847 us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-09-30 0001961847 INHD:IMSCATAndCBTMember 2025-10-01 2025-12-31 0001961847 INHD:IMSCATAndCBTMember 2024-10-01 2024-12-31 0001961847 INHD:CoreModuLLCMember 2025-10-01 2025-12-31 0001961847 2021-09-08 0001961847 us-gaap:CommonStockMember 2022-11-30 2022-11-30 0001961847 2023-07-23 0001961847 2023-07-24 0001961847 2024-10-09 2024-10-09 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2022-12-01 2022-12-31 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2022-12-31 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2023-02-01 2023-02-28 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2023-02-28 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2023-03-01 2023-03-31 0001961847 us-gaap:CommonStockMember us-gaap:InvestorMember 2023-03-31 0001961847 srt:ChiefFinancialOfficerMember 2023-06-20 2023-06-20 0001961847 INHD:OneNonemployeeContractorMember 2023-06-20 2023-06-20 0001961847 2023-06-20 0001961847 INHD:OneNonemployeeContractorMember 2024-01-01 2024-01-01 0001961847 us-gaap:IPOMember 2023-12-18 0001961847 us-gaap:IPOMember 2023-12-18 2024-12-18 0001961847 us-gaap:IPOMember 2023-12-18 2023-12-18 0001961847 srt:MaximumMember 2023-12-18 0001961847 srt:MaximumMember 2023-12-18 2023-12-18 0001961847 2023-12-18 0001961847 INHD:WarrantAssumptionAgreementMember 2024-03-01 0001961847 INHD:WarrantAssumptionAgreementMember 2024-03-01 2024-03-01 0001961847 INHD:WarrantAssumptionAgreementMember 2025-12-31 0001961847 2023-12-14 2023-12-14 0001961847 2023-12-19 2023-12-19 0001961847 us-gaap:InvestorMember 2024-10-31 2024-10-31 0001961847 us-gaap:InvestorMember 2024-10-31 0001961847 INHD:NineNonUSInvestorMember 2024-11-13 2024-11-13 0001961847 INHD:NineNonUSInvestorMember 2024-11-13 0001961847 INHD:NineNonUSInvestorMember 2024-12-11 2024-12-11 0001961847 INHD:NineNonUSInvestorMember 2024-12-11 0001961847 srt:ChiefExecutiveOfficerMember 2025-01-16 2025-01-16 0001961847 srt:ChiefFinancialOfficerMember 2025-01-16 2025-01-16 0001961847 INHD:EmployeeMember 2025-05-28 2025-05-28 0001961847 us-gaap:InvestorMember 2025-06-02 2025-06-02 0001961847 us-gaap:InvestorMember 2025-06-02 0001961847 us-gaap:CommonStockMember 2025-01-27 2025-01-27 0001961847 us-gaap:CommonStockMember 2025-06-20 2025-06-20 0001961847 us-gaap:CommonStockMember 2025-06-02 2025-06-02 0001961847 us-gaap:CommonStockMember 2025-06-20 0001961847 2025-07-04 0001961847 us-gaap:CommonStockMember 2025-08-27 2025-08-27 0001961847 us-gaap:CommonStockMember 2025-08-27 0001961847 us-gaap:CommonStockMember 2025-09-10 2025-09-10 0001961847 us-gaap:CommonStockMember 2025-09-10 0001961847 us-gaap:WarrantMember 2025-09-10 2025-09-10 0001961847 us-gaap:WarrantMember 2025-09-10 0001961847 2025-09-10 0001961847 2025-09-10 2025-09-10 0001961847 2025-09-26 2025-09-26 0001961847 us-gaap:WarrantMember 2025-09-26 2025-09-26 0001961847 us-gaap:CommonStockMember 2025-09-26 2025-09-26 0001961847 INHD:PlacementSharesMember srt:MaximumMember 2025-11-12 2025-11-12 0001961847 us-gaap:CommonStockMember 2025-11-12 2025-12-15 0001961847 INHD:SecuritiesPurchaseAgreementMember 2025-12-26 2025-12-26 0001961847 INHD:SecuritiesPurchaseAgreementMember 2025-12-26 0001961847 srt:MaximumMember 2025-12-31 0001961847 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember INHD:ThreeCustomersMember 2025-10-01 2025-12-31 0001961847 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember INHD:TwoCustomersMember 2024-10-01 2024-12-31 0001961847 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember INHD:TwoSuppliersMember 2025-10-01 2025-12-31 0001961847 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember INHD:TwoSuppliersMember 2024-10-01 2024-12-31 0001961847 2024-12-01 2024-12-31 0001961847 country:HK 2025-10-01 2025-12-31 0001961847 country:HK 2024-10-01 2024-12-31 0001961847 us-gaap:RestrictedStockMember 2025-10-01 2025-12-31 0001961847 us-gaap:RestrictedStockMember 2024-10-01 2024-12-31 0001961847 us-gaap:SubsequentEventMember 2026-01-16 2026-01-16 0001961847 us-gaap:SubsequentEventMember 2026-01-16 0001961847 INHD:MegabyteSolutionsLimitedMember us-gaap:SubsequentEventMember 2026-02-02 0001961847 us-gaap:SubsequentEventMember 2026-02-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft utr:acre INHD:Integer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended ~~June~~December 3031, 2025
☐	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934:

For the transition period from __________ to __________.

Commission file number: 001-41882

INNO HOLDINGS INC.

(Exact name of registrant as specified in its charter)

Texas		87-4294543
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

RM1, 5/F, No. 43 Hung To Road, Kwun Tong,

Kowloon, Hong Kong 999077

(Address of principal executive offices, including ZIP Code)

~~(800) 909~~+852-~~8800~~54795450

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, no par value		INHD		The Nasdaq Stock Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~June~~January 30, ~~2025~~2026, there were 78,~~748~~413,~~482~~224 shares of common stock, no par value, issued and outstanding.

Table of Contents

		Page
PART I	FINANCIAL INFORMATION
ITEM 1:	Financial Statements
	Condensed Consolidated Balance Sheets - June 30, 2025 (Unaudited) and September 30, 2024	1
	Condensed Consolidated Balance Sheets – December 31, 2025 (Unaudited) and September 30, 2025	1
	Condensed Consolidated Statements of Operations - Three Months and Nine Months Ended June 30, 2025 and 2024 (Unaudited)	2
	Condensed Consolidated Statements of Operations - Three Months Ended December 31, 2025 and 2024 (Unaudited)	2
	Condensed Consolidated Statements of Changes in Stockholders’ Equity - Three Months and Nine Months Ended June 30, 2025 and 2024 (Unaudited)	3
	Condensed Consolidated Statements of Changes in Stockholders’ Equity - Three Months Ended December 31, 2025 and 2024 (Unaudited)	3
	Condensed Consolidated Statements of Cash Flows - Three Months and Nine Months Ended June 30, 2025 and 2024 (Unaudited)	4
	Condensed Consolidated Statements of Cash Flows - Three Months Ended December 31, 2025 and 2024 (Unaudited)	4
	Notes to Unaudited Condensed Consolidated Financial Statements	5
ITEM 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1922
ITEM 3:	Quantitative and Qualitative Disclosures About Market Risk	2527
ITEM 4:	Controls and Procedures	2527
PART II	OTHER INFORMATION	2628
ITEM 1:	Legal Proceedings	2628
ITEM 1A:	Risk Factors	2628
ITEM 2:	Unregistered Sales of Equity Securities and Use of Proceeds	2628
ITEM 3:	Defaults Upon Senior Securities	2729
ITEM 4:	Mine Safety Disclosures	2729
ITEM 5:	Other Information	2729
ITEM 6:	Exhibits	2829
SIGNATURES		2930

INNO HOLDINGS INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

	June 30, 2025 (unaudited)		September 30, 2024
	December 31, 2025		September 30, 2025
	(unaudited)
ASSETS
Current assets
Cash and cash equivalent	$	437,~~385~~149,~~289~~913	$	110,~~077~~130,~~138~~942
Accounts receivable, net		-		-
Inventories		2,021,409		2,107,000
Inventories		2,058,800		-
Prepayments and other current assets		5,965,345		1,567,441
Prepayments and other current assets		1,387,476		65,797
Total current assets		45,136,667		13,805,383
Current assets from discontinued operations		-		1,145,673
Total current assets		7,831,565		2,288,608
Non-current assets
Goodwill, net		-		-
Equity investment		2,200,000		2,200,000
Equity investment		1,000,000		-
Total non-current assets		2,200,000		2,200,000
Non-current assets from discontinued operations		-		1,880,729
Total assets	$	47,336,667	$	16,005,383
Total non-current assets		1,000,000		1,880,729
Total assets	$	8,831,565	$	4,169,337
LIABILITIES AND EQUITY
Current liabilities
Other payables and accrued liabilities		830,702		138,700
Advance from customer		-		100,000
Other payables and accrued liabilities		128,408		318,110
Short-term loan payable		50,000		50,000
Current liabilities from discontinued operations		-		1,124,153
Total current liabilities		178,408		468,110
Total current liabilities		880,702		1,312,853
Non-current liabilities
Non-current liabilities from discontinued operations		-		58,948
SEPA liabilities		-		370,546
Total non-current liabilities		-		58370,~~948~~546
Total liabilities		~~880~~178,~~702~~408		1838,~~371,801~~656
Commitments and contingency		—		—

INNO HOLDINGS INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets

	June 30, 2025 (unaudited)			September 30, 2024
	December 31, 2025			September 30, 2025
	(unaudited)
Stockholders’ Equity
Common stock, no par value; 100,000,000 shares authorized; 7,748,482 and 2,279,960 shares issued and outstanding on June 30, 2025 and September 30, 2024*		—			—
Common stock, no par value; 100,000,000 shares authorized; 7,081,224 and 539,520 shares issued and outstanding on December 31, 2025 and September 30, 2025*		-			-
Additional paid in capital		2162,~~753~~004,~~739~~884			1029,~~748~~984,~~534~~734
Subscription receivable		(293,750	)
Accumulated deficit		(14,846,625	)		(14,818,007	)
Accumulated deficit		(13,509,126	)		(7,738,644	)
Total equity		47,158,259			15,166,727
Non-controlling interest		-			(212,354	)
Total liabilities and equity	$	47,336,667		$	16,005,383
Total equity		7,950,863			2,797,536
Total liabilities and equity	$	8,831,565		$	4,169,337

* On ~~October~~December 922, ~~2024~~2025, the Company completed a 1-for-1024 reverse stock split of its issued and outstanding common stock, no par value, (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each share of common stock issued and outstanding immediately prior to ~~October~~December 922, ~~2024~~2025 were ~~automatically~~ converted into one twenty-~~tenth~~fourth (1/1024) of a share of common stock. The Reverse Stock Split did not reduce the number of authorized shares of Common Stock and did not change the par value of the Common Stock. The Reverse Stock Split affected all stockholders uniformly. Except to the extent that the Reverse Stock Split resulted in the stockholders’ fractional shares being rounded up on the participant level, no other effects affect stockholder’s ownership percentage of the Company’s shares of Common Stock. ~~199,787 fractional shares were issued in connection with the Reverse Stock Split.~~ All references to number of shares, and to per share information in the consolidated financial statements have been retroactively adjusted.

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

INNO HOLDINGS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

For the Three Months ~~and Nine Months~~ Ended ~~June~~December 3031, 2025 and 2024 (unaudited)

	2025			2024			2025			2024
	For the Three month Ended December 31,
	For the Three Months Ended June 30,						For the Nine Months Ended June 30,
	2025			2024
	2025			2024			2025			2024
REVENUES:
REVENUES:
Revenue - products	$	1,456,481		$	196,000
Revenue - products	$	1,086,250		$	-		$	1,760,350		$	-
Total revenue		1,456,481			196,000
Total revenue		1,086,250			-			1,760,350			-
COSTS OF REVENUE:
COSTS OF REVENUE:
Costs of goods sold		1,382,346			180,000
Costs of goods sold		1,102,300			-			1,718,900			-
Total cost of sales		1,382,346			180,000
Total cost of sales		1,102,300			-			1,718,900			-
GROSS PROFIT		74,135			16,000
GROSS (LOSS)/ PROFIT		(16,050	)		-			41,450			-
OPERATING EXPENSES:
OPERATING EXPENSES:
Selling, general and administrative expenses (exclusive of expenses shown separately below)		560,003			470,592
Selling, general and administrative expenses (exclusive of expenses shown separately below)		1,544,590			188,667			3,425,985			664,665
Impairment loss on goodwill		-			3,514
Impairment loss on goodwill		-			-			3,514			-
Total operating expenses		560,003			474,106
Total operating expenses		1,544,590			188,667			3,429,499			664,665
LOSS FROM OPERATIONS		(485,868	)		(458,106	)
LOSS FROM OPERATIONS		(1,560,640	)		(188,667	)		(3,388,049	)		(664,665	)
OTHER INCOME (EXPENSE)
OTHER INCOME (EXPENSE)
Interest income (expenses), net		86,729			372
Interest income, net		14,549			19,706			25,966			91,468
Change in fair value of SEPA		370,546			-
Gain/(loss) on investment disposal		100			-			(2,152,522)			-
Other non-operating expense		(25	)		(6	)
Other non-operating income (expense)		(297	)		(647	)		9,436			138,623
Total other (expenses) income, net		457,250			366
Total other income (expenses), net		14,352			19,059			(2,117,120	)		230,091
LOSS BEFORE INCOME TAXES		(28,618	)		(457,740	)
LOSS BEFORE INCOME TAXES		(1,546,288	)		(169,608	)		(5,505,169	)		(434,574	)
INCOME TAX EXPENSE		-			-
PROVISION FOR INCOME TAXES		-			-			-			800
NET LOSS FROM CONTINUING OPERATIONS		(28,618	)		(457,740	)
NET LOSS FROM CONTINUING OPERATIONS		(1,546,288	)		(169,608	)		(5,505,169	)		(435,374	)
Net loss from discontinued operations		-			(147,669	)
Net loss from discontinued operations		-			(881,273	)		(195,796	)		(2,526,698	)
NET LOSS	$	(28,618	)	$	(605,409	)
NET LOSS	$	(1,546,288	)	$	(1,050,881	)	$	(5,700,965	)	$	(2,962,072	)
Non-controlling interest		-			1,712
Non-controlling interest		-			13,821			69,517			(35,395	)
NET LOSS ATTRIBUTABLE TO INNO HOLDINGS INC.	$	(28,618	)	$	(603,697	)
NET LOSS ATTRIBUTABLE TO INNO HOLDINGS INC.	$	(1,546,288	)	$	(1,064,702	)	$	(5,770,482	)	$	(2,926,677	)
WEIGHTED AVERAGE NUMBER OF COMMON STOCK*
WEIGHTED AVERAGE NUMBER OF COMMON STOCK*
Basic and Diluted		2,081,643			115,934
Basic and Diluted		5,154,308			2,075,173			4,100,692			2,003,092
LOSSES PER SHARE
LOSSES PER SHARE
Basic and Diluted from Continuing Operation		(0.01	)		(3.95	)
Basic and Diluted from Continuing Operation		(0.30	)		(0.08	)		(1.34	)		(0.22	)
Basic and Diluted from Discontinuing Operation		-			(1.26	)
Basic and Diluted from Discontinuing Operation		-			(0.43	)		(0.07	)		(1.24	)
Basic and Diluted, Total	$	(0.01	)	$	(5.21	)
Basic and Diluted, Total	$	(0.30	)	$	(0.51	)	$	(1.41	)	$	(1.46	)

* On ~~October~~December 922, ~~2024~~2025, the Company completed a 1-for-1024 reverse stock split of its issued and outstanding common stock, no par value, (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each share of common stock issued and outstanding immediately prior to ~~October~~December 922, ~~2024~~2025 were ~~automatically~~ converted into one twenty-~~tenth~~fourth (1/1024) of a share of common stock. The Reverse Stock Split did not reduce the number of authorized shares of Common Stock and did not change the par value of the Common Stock. The Reverse Stock Split affected all stockholders uniformly. Except to the extent that the Reverse Stock Split resulted in the stockholders’ fractional shares being rounded up on the participant level, no other effects affect stockholder’s ownership percentage of the Company’s shares of Common Stock. ~~199,787~~All ~~fractional~~references ~~shares~~to ~~were~~number ~~issued~~of inshares, ~~connection~~and ~~with~~to ~~the~~per ~~Reverse~~share ~~Stock~~information ~~Split.~~in ~~The~~the ~~computation~~consolidated offinancial ~~basic~~statements ~~and~~have ~~diluted~~been ~~Losses Per Share were~~ retroactively adjusted ~~for all periods presented~~.

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

INNO HOLDINGS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Changes in Stockholders’ Equity

For the ~~Nine~~Three Months Ended ~~June~~December 3031, 2025 and 2024

	Shares		Amount*		Capital			Deficit			interest			Receivable			Total
				*
	Common Stock*				Additional Paid in			Accumulated			Non- controlling			~~Subscription~~
	Shares		Amount		Capital			Deficit			interest			~~Receivable~~Total			~~Total~~
Balance, September 30, 2023		1,825,173	$	-	$	2,830,000		$	(4,524,815	)	$	(248,771	)	$	-		$	(1,943,586	)
Balance, September 30, 2024		94,998	$	-	$	10,748,534		$	(7,738,644	)	$	(212,354	)	$	2,797,536
Net loss		-		-		-			(~~801~~603,~~518~~697	)		(151,~~746~~712	)		(605,409	)		~~(817,264~~	)
Shares issued upon IPO completion		250,000		-		7,859,534			-			-			-			7,859,534
Shares issued for cash		80,382		-		7,250,000			-			-			7,250,000
Balance, December 31, 2023 (unaudited)		2,075,173	$	-	$	10,689,534		$	(5,326,333	)	$	(264,517	)		-		$	5,098,684
Balance, December 31, 2024 (unaudited)		175,380	$	-	$	17,998,534		$	(8,342,341	)	$	(214,066	)	$	9,442,127
Net loss		-		-		-			(1,060,457	)		(33,470	)		-			(1,093,927	)
Disposal of subsidiary		-		-		-			-			73,715			-			73,715
Warrants assumption		-		-		(13,000	)		-			-			-			(13,000	)
Balance, March 31, 2024 (unaudited)		2,075,173		-		10,676,534			(6,386,790	)		(224,272	)		-			4,065,472
Net loss		-		-		-			(1,064,702	)		13,821			-			(1,050,881	)
Balance, June 30, 2024 (unaudited)		2,075,173	$	-	$	10,676,534		$	(7,451,492	)	$	(210,451	)		-		$	3,014,591

	Common Stock*				Additional Paid in		Accumulated			Non- controlling			~~Subscription~~
	Shares		Amount		Capital		Deficit			interest			~~Receivable~~Total			~~Total~~
Balance, September 30, 2024		2,279,960	$	-	$	10,748,534	$	(7,738,644	)	$	(212,354	)	$	-		$	2,797,536
Balance, September 30, 2025		539,520	$	-	$	29,984,734	$	(14,818,007	)	$	-		$	15,166,727
Balance		2,279,960	$	-	$	10,748,534	$	(7,738,644	)	$	(212,354	)	$	-		$	2,797,536
Net loss		-		-		-		(28,618	)		-			(28,618	)
Net loss		-		-		-		(603,697	)		(1,712	)		-			(605,409	)
Fractional shares round up due to reverse stock split		37		-		-		-			-			-
Shares issued for cash		16,~~929~~541,~~167~~667		-		732,~~250~~020,~~000~~150		-			-			-32,020,150			~~7,250,000~~
Balance, December 31, 2024 (unaudited)		4,209,127	$	-	$	17,998,534	$	(8,342,341	)	$	(214,066	)		-		$	9,442,127
Balance, December 31, 2025 (unaudited)		7,081,224	$	-	$	62,004,884	$	(14,846,625	)	$	-		$	47,158,259
Balance		4,209,127	$	-	$	17,998,534	$	(8,342,341	)	$	(214,066	)		-		$	9,442,127
Net loss		-		-		-		(3,620,497	)		71,229			-			(3,549,268	)
Disposal of subsidiary		-		-				-			142,837			-			142,837
Stock-based compensation		201,355		-		1,041,005		-			-			-			1,041,005
Balance, March 31, 2025 (unaudited)		4,410,482	$	-	$	19,039,539	$	(11,962,838	)	$	-			-		$	7,076,701
Balance		4,410,482	$	-	$	19,039,539	$	(11,962,838	)	$	-			-		$	7,076,701
Net loss		-		-		-		(1,546,288	)		-			-			(1,546,288	)
Proceeds from sale of common stock		2,458,000		-		1,579,000		-			-			(293,750	)		1,285,250
Stock-based compensation		880,000		-		1,135,200		-			-			-			1,135,200
Balance, June 30, 2025 (unaudited)		7,748,482	$	-	$	21,753,739	$	(13,509,126	)	$	-		$	(293,750	)	$	7,950,863
Balance		7,748,482	$	-	$	21,753,739	$	(13,509,126	)	$	-		$	(293,750	)	$	7,950,863

* On ~~October~~December 922, ~~2024~~2025, the Company completed a 1-for-1024 reverse stock split of its issued and outstanding common stock, no par value, (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each share of common stock issued and outstanding immediately prior to ~~October~~December 922, ~~2024~~2025 were ~~automatically~~ converted into one twenty-~~tenth~~fourth (1/1024) of a share of common stock. The Reverse Stock Split did not reduce the number of authorized shares of Common Stock and did not change the par value of the Common Stock. The Reverse Stock Split affected all stockholders uniformly. Except to the extent that the Reverse Stock Split resulted in the stockholders’ fractional shares being rounded up on the participant level, no other effects affect stockholder’s ownership percentage of the Company’s shares of Common Stock. ~~199,787~~All ~~fractional~~references to number of shares, ~~were~~and ~~issued~~to inper ~~connection~~share ~~with~~information in the ~~Reverse~~consolidated ~~Stock~~financial ~~Split~~statements have been retroactively adjusted.

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

INNO HOLDINGS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

	For the Three Months Ended December 31,
	2025			2024
	For the Nine Months Ended June 30, (unaudited)
	2025			2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss from continuing operation	$	(528,~~505,169~~618	)	$	(~~435~~457,~~374~~740	)
Net loss from discontinuing operation		~~(265,313~~-	)		(2147,~~491,303~~669	)
Adjustments to reconcile net income to cash used in operating activities:
Stock-based compensation expense		~~2,185,205~~-			839,~~333~~000
Loss from investment disposal		2,152,522			-
Impairment loss		-			3,514
Impairment loss		3,514			-
Change in fair value of SEPA		(370,546	)		-
Accounts receivable		-			-
Inventories		85,591			(1,893,000	)
Inventories		(2,058,800	)		-
Prepayments and other current assets		(4,397,904	)		757,032
Deferred offering costs		-			(51,701	)
Advance from customer		(100,000	)		-
Prepayments and other current assets		1,026,834			(2,775,684	)
Other payables and accrued liabilities		(189,702	)		53,688
Accounts payable		(805,579	)		(216,239	)
Operating cash flow used by discontinued operations		-			(421,170	)
Operating lease liabilities		-			(39,221	)
Net cash used in operating activities		(5,001,179	)		(2,096,345	)
Other payables and accrued liabilities		(38,912	)		177,822
Other current liabilities		-			-
Operating cash flow used by discontinued operations		(398,948	)		886,614
Net cash used in operating activities		(3,704,646	)		(4,861,753	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of investment in equity investee		~~(1,672,600~~-	)		-(1,401,300	)
Proceed from investment disposal		177,000			-
Net cash used in investing activities by discontinued operations		-			(26,854	)
Net cash used in investing activities by discontinued operations		(26,853	)		(412,231	)
Net cash used in investing activities		-			(1,428,154	)
Net cash used in investing activities		(1,522,453	)		(412,231	)
CASH FLOWS FROM FINANCING ACTIVITY:
CASH FLOWS FROM FINANCING ACTIVITIES:
Shares issued for cash		32,020,150			7,250,000
Proceeds from related parties		-			-
Net cash provided by financing activity		32,020,150			7,250,000
Payments to related parties		-			(627,000	)
CHANGES IN CASH AND CASH EQUIVALENT		27,018,971			3,725,501
Payments to short-term loans		-			(180,000	)
CASH AND CASH EQUIVALENT, beginning of period		10,130,942			1,077,138
Warrants assumption		-			(13,000	)
CASH AND CASH EQUIVALENT, ending of period	$	37,149,913		$	4,802,639
Proceeds from IPO		-			8,450,000
Proceeds from issuance of shares		8,535,250			-
Net cash used in financing activities by discontinued operations		-			(472,197	)
Net cash provided by financing activities		8,535,250			7,157,803
CHANGES IN CASH AND CASH EQUIVALENT		3,308,151			1,883,819
CASH AND CASH EQUIVALENT, beginning of period		1,077,138			1,939
CASH AND CASH EQUIVALENT, ending of period	$	4,385,289		$	1,885,758
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income tax	$	—		$	800
Cash paid for interest	$	-		$	22,145
Noncash deferred offering costs offset to APIC upon IPO completion	$	-		$	590,466
Right-of-use assets obtained in exchange for operating lease liabilities	$	-		$	356,741
Deposit applied to lease liability	$	-		$	39,699

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

INNO HOLDINGS INC. AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

Note 1 — Nature of business and organization

INNO HOLDINGS, INC., a Texas corporation (the “Company”), was incorporated on September 8, 2021. The Company is ~~principally~~currently ~~engaged~~an innovative technology company that engages in the ~~marketing~~business of recycled consumer electronic devices. The Company sources and ~~sale~~purchases ofpre-owned consumer ~~construction~~electronic ~~products~~devices ~~along~~such ~~with~~as ~~full~~smartphones and tablets from suppliers and sell the electronic devices to wholesalers that re-~~scope~~sell these ~~construction~~products ~~services~~to their wholesale and/or retail customers in Southeast Asia, Middle East Asia, Europe and other regions. The recycled consumer electronic devices offered by the USCompany include smartphones (various models of iPhone) and tablets (various models of iPad). The Company conducts its business of recycled consumer electronic devices through two Hong Kong-based wholly-owned subsidiaries Lear Group Limited and Baymax High Technology Co., Limited, acquired by the Company in October and December 2024, respectively.

On January 18, 2022, the Company formed a limited liability company, Castor Building Tech LLC (“CBT”), in California. The Company owned 53% of the equity interest in CBT. On October 16, 2023, the Company and the noncontrolling interest parties reached a new ownership agreement that the Company’s ownership increased to 55%. According to the new ownership agreement, the ownership percentage change is retroactively effective from January 18, 2022. The impact of historical noncontrolling interest allocation from this ownership percentage change is immaterial.

Effective as of January 21, 2022, the Company acquired 100% of the ordinary shares of Inno Metal Studs Corp. (“IMSC”), a Texas corporation incorporated on October 31, 2019. Pursuant to the terms of the Share Purchase Agreement with IMSC’s former sole owner and CEO of the Company, Mr. Dekui Liu, the Company issued 15,170,000 shares of its common stock to Mr. Dekui Liu in exchange for his 100% ownership in IMSC. Upon completion of the transaction, IMSC became a 100% owned subsidiary of the Company.

Inno Research Institute LLC (“IRI”), a Texas limited liability company was formed on September 8, 2021, is a 65% owned subsidiary of IMSC. On January 27, 2024, IRI was voluntarily terminated and resulted in a disposal loss of $23,715. The R&D activities carried out by IRI will be transferred to Inno AI Tech Corp, a new subsidiary of the Company.

On January 21, 2024, the Company incorporated Inno Disrupts Inc., a wholly owned subsidiary in Texas. The purpose of Inno Disrupts Inc. is to remodel buildings using the Company’s framing steel products, enhance producing and marketing capabilities, manage the designated buildings in US, and other activities.

On February 11, 2024, the Company incorporated Inno AI Tech Corp., a wholly owned entity to conduct AI tech research and consulting activities.

On October 18, 2024, the Company completed the acquisition of 10,000 shares of Lear Group Limited (“Lear”), a Hong Kong company, from its shareholder for a total consideration of $1,300. As a result of this transaction, Lear became a wholly-owned subsidiary of the Company. The acquisition of Lear was undertaken to support the Company’s entry into a new business initiative focused on electronic product trading.

On December 13, 2024, the Company completed the acquisition of 10,000 shares of Baymax High Technology Co., Limited (“Baymax”), a Hong Kong company, from its shareholder for a total consideration of $1,300. As a result of this transaction, Baymax became a wholly-owned subsidiary of the Company.

On March 4, 2025, the Company entered into a Share Purchase Agreement with Architectix Limited, pursuant to which the Company sold all issued and outstanding shares it owns in Inno Metal Studs Corp and Inno AI Tech Corp for an aggregate purchase price of $1,000.

On March 28, 2025, the Company entered into a Membership Interest Purchase Agreement with Strucraft Group Limited, pursuant to which the Company sold all the membership interest it owns in Castor Building Tech LLC, which represents 55% of the outstanding membership interest in Castor Building Tech LLC, for an aggregate purchase price of $1,000.

On April 8, 2025, the Company entered into a Share Purchase Agreement with Strucraft Group Limited, pursuant to which the Company sold all issued and outstanding shares it owns in Inno Disrupts Inc. for an aggregate purchase price of $100.

Note 2 — Basis of Presentation and Summary of significant accounting policies

Basis of presentation

The accompanying financial statements have been prepared in accordance with the generally accepted accounting principles in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”). The Company’s fiscal year end date is September 30.

Certain information and footnote disclosures normally included in the Company’s annual audited financial statements and accompanying notes have been condensed or omitted in this accompanying interim consolidated financial statements and footnotes. Accordingly, the accompanying interim condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended September 30, ~~2024~~2025, filed with the Securities and Exchange Commission (“SEC”) on December 1915, ~~2024~~2025.

In the opinion of management, these unaudited consolidated financial statements include all adjustments and accruals, consisting only of normal, recurring adjustments that are necessary for a fair statement of the results of all interim periods reported herein. The results of the interim periods are not necessarily indicative of the results expected for the full fiscal year or any other interim period or any future year or period.

Consolidated Principles of consolidation

The Consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company balances and transactions have been eliminated.

Going concern

As of ~~June~~December 3031, 2025, the Company had total cash and cash equivalent of $ 437,~~385~~149,~~289~~913 and accumulated deficit of $1314,~~509~~846,~~126~~625. For the ~~nine~~three months ended ~~June~~December 3031, 2025, the Company had incurred a net loss of $528,~~700,965~~618 and ~~used~~ net cash used cash in operations of $35,~~704~~001,~~646~~179. These ~~conditions~~ conditions raise substantial doubt about the Company’s ability to continue as a going concern. Based on our current operating and investing plan, the management has concluded that substantial doubt is not alleviated regarding the Company’s ability to continue as a going concern for 12 months from the date of issuance of these financial statements.

The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations, and/or obtaining additional financing from its shareholders or other sources, as may be required.

Standby Equity Purchase Agreement

On July 4, 2025, the Company entered into the SEPA with the Investors. Pursuant to SEPA, the Company has the right, but not the obligation, to issue and sell, from time to time at the Company’s discretion, up to $6 million of shares of our common stock to the Investors at a price equal to 40%, or a percentage between 20% and 40% as determined by us, of the Minimum Price, or $1.20, subject to specified limitations and conditions, including a $0.5 million minimum per drawdown and a 9.99% beneficial ownership cap per investor. The SEPA has a three-year term and may be terminated earlier by the Company, and the Company expect to use any proceeds for working capital and general corporate purposes. The SEPA, in its entirety, is classified as a derivative liability because it did not meet the equity classification criteria under ASC 815-10, Derivatives and Hedging (“ASC 815-10”). The SEPA derivative is valued based on a scenario-based valuation model utilizing the expected draws, probability of the draws and risk-free rate inputs. The change in the fair value of the derivative is recorded in the Condensed Consolidated Statements of Operations. The SEPA was terminated by mutual agreement between the Investors and the Company on December 30, 2025.

Use of estimates and assumptions

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities reported and disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates.

Cash and cash equivalents

Cash and cash equivalents consist of amounts held as cash on hand, bank and money market deposits, and marketable securities with maturities of less than 90 days.

From time to time, the Company may maintain bank balances in interest bearing accounts in excess of the $250,000, which is currently the maximum amount insured by the Federal Deposit Insurance Corporation for interest bearing accounts (there is currently no insurance limit for deposits in noninterest bearing accounts). The Company has not experienced any losses with respect to cash. Management believes the Company is not exposed to any significant credit risk with respect to its cash.

Accounts receivable

During the ordinary course of business, the Company extends unsecured credit to its customers. Accounts receivable are stated at the amount the Company expects to collect from customers. Management reviews its accounts receivable balances each reporting period to determine if an allowance for credit loss is required.

In October 2020, the Company adopted ASU 2016-13, Topics 326 — Credit Loss, Measurement of Credit Losses on Financial Instruments, which replaces the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology, for its accounting standard for its trade accounts receivable.

The Company continuously monitors the recoverability of accounts receivable. If there are any indicators that a customer may not make payment, the Company may consider making provision for non-collectability for that particular customer. At the same time, the Company may cease further sales or services to such customer. The following are some of the factors that the Company develops allowance for credit losses:

	●	the customer fails to comply with its payment schedule;
	●	the customer is in serious financial difficulty;
	●	a significant dispute with the customer has occurred regarding job progress or other matters;
	●	the customer breaches any of its contractual obligations;
	●	the customer appears to be financially distressed due to economic or legal factors;
	●	the business between the customer and the Company is not active; and
	●	other objective evidence indicates non-collectability of the accounts receivable.

The adoption of the credit loss accounting standard has no material impact on the Company’s consolidated financial statements. Accounts receivable are recognized and carried at carrying amount less an allowance for credit losses, if any. The Company maintains an allowance for credit losses resulting from the inability of its customers to make required payments based on contractual terms. The Company reviews the collectability of its receivables on a regular and ongoing basis. The Company has also included in the calculation of allowance for credit losses based on its customers’ businesses and their ability to pay their accounts receivable. After all attempts to collect a receivable have failed, the receivable is written off against the allowance. The Company also considers external factors to the specific customer, including current conditions and forecasts of economic conditions. In the event we recover amounts previously written off, we will reduce the specific allowance for credit losses.

Fair values of financial instruments

ASC 825, “Disclosures about Fair Value of Financial Instruments,” requires disclosure of fair value information about financial instruments. ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements.

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and all other current assets and liabilities are approximate fair values due to their short-term nature.

For other financial instruments to be reported at fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines the fair value of its financial instruments based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

Level 1 —	Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

Level 2 —	Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

Level 3 —	Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

AsOn July 4, 2025, the Company entered into the SEPA with the Investors. Upon execution of ~~June~~the 30SEPA, ~~2025~~the ~~and~~Company ~~September~~determined 30the fair value of the SEPA derivative liability to be $635,669 ~~2024~~based on a scenario-based model. As of December 31, 2025, the Company ~~did~~terminated ~~not~~the SEPA ~~have~~and ~~any~~determined the fair value of the SEPA derivative liability to be $Nil; the change in fair value is recognized in other ~~financial~~income and ~~instruments~~expense. ~~reported~~The atcarrying amounts of SEPA derivative liability represent the remeasurement to fair value each reporting period based on unobservable, or Level 3, inputs, using assumptions made by us, including the market price of our common stock and the observed volatility of a peer group of companies. The SEPA was terminated by mutual agreement between the Investors and the Company on December 30, 2025.

The following tables summarize the changes in fair value of SEPA derivative liability for the three months ended December 31, 2025. The SEPA derivative liabilities were not present for the three months ended December 31, 2024.

Level 3 Liabilities

Fair Value at

September 30,

2025

Issuances

(Settlements)

Change in Unrealized (Gains) Losses

Fair Value at December 31,
2025

SEPA derivative liability

370,546

Revenue recognition

The Company has adopted Accounting Standards Codification (“ASC”) 606 since its inception and recognizes revenue from product and service sales revenues, net of promotional discounts and return allowances, if any, when the following revenue recognition criteria are met: a contract has been identified, separate performance obligations are identified, the transaction price is determined, the transaction price is allocated to separate performance obligations and revenue is recognized upon satisfying each performance obligation. The Company transfers the risk of loss or damage upon delivery, therefore, revenue from product sales is recognized when it is delivered to the customer. For services, all sales are recognized upon completion based on terms stated in the sales agreements.

The Company evaluates the criteria of ASC 606 — Revenue Recognition Principal Agent Considerations in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. Generally, when the Company is primarily responsible for fulfilling the promise to provide a specified good or service, the Company is subject to inventory risk before the good or service has been transferred to a customer and the Company has discretion in establishing the price, revenue is recorded at gross.

Payments received prior to the delivery of goods to customers are recorded as unearned revenue.

Sales discounts are recorded in the period in which the related sale is recognized. Sales return allowances are estimated based on historical amounts and are recorded upon recognizing the related sales. Shipping and handling costs are recorded as selling expenses.

Revenue from electronic products trading is recognized at the point of delivery when the customer obtains control of the products.

Costs and expenses

Costs and expenses are operating expenses, which consist of costs of material and labor, selling, general and administrative expenses, and depreciation, are expensed as incurred.

Inventory

Inventory consists of material and finished goods ready for sale and is stated at the lower of cost or net realizable value. The Company values its inventory using the FIFO costing method. The Company’s policy is to include as a part of cost of goods sold any freight incurred to ship the product from its vendors to warehouses. Outbound freight costs related to shipping costs to customers are considered periodic costs and are reflected in selling expenses. The Company regularly reviews inventory and considers forecasts of future demand, market conditions and product obsolescence.

If the estimated realizable value of the inventory is less than cost, the Company makes provisions in order to reduce its carrying value to its estimated net realizable value. The Company regularly assesses its inventory for obsolescence and records an allowance only when the inventory is no longer suitable for reproduction. The Company’s inventory generally has a long life cycle and does not become obsolete quickly.

Deferred offering costs

The Company capitalizes certain legal, accounting and other third-party fees that are directly related to an equity financing that is probable of successful completion until such financing is consummated. After consummation of an equity financing, these costs are recorded as a reduction of the proceeds received as a result of the financing. Should a planned equity financing be abandoned, terminated or significantly delayed, the deferred offering costs are immediately written off to operating expenses in the consolidated statements of operations in the period of determination.

Property and equipment

Property and equipment is stated at their historical cost, less accumulated depreciation. Depreciation on property and equipment is provided using the straight-line method over the estimated useful lives of the assets as follows:

Machinery and equipment		7 years

Office equipment		5 years

Motor vehicles		5 years

Leasehold improvements		the shorter of the lease term or the estimated useful life of the improvements

Expenditures for renewals and betterments are capitalized while repairs and maintenance costs are normally charged to the statement of operations in the year in which they are incurred. In situations where it can be clearly demonstrated that the expenditure has resulted in an increase in the future economic benefits expected to be obtained from the use of the asset, the expenditure is capitalized as an additional cost of the asset.

Upon sale or disposal of an asset, the historical cost and related accumulated depreciation or amortization of such asset ~~were~~was removed from their respective accounts and any gain or loss is recorded in the statements of income.

The Company reviews the carrying value of property and equipment for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of assets. The factors considered by management in performing this assessment include current operating results, trends and prospects, the manner in which the property is used, and the effects of obsolescence, demand, competition and other economic factors. Based on this assessment, no impairment expenses for property and equipment were recorded during the three ~~and nine~~ months ended ~~June~~December 3031, 2025 and 2024.

Goodwill

Goodwill represents the excess of the purchase price of an acquired business over the amount assigned to the assets acquired and liabilities assumed. Goodwill is not amortized but are subject to impairment testing on an annually basis or more frequently if events or circumstances indicate a potential impairment. These events or circumstances could include a significant change in the business climate, regulatory environment, established business plans, operating performance indicators or competition. Potential impairment indicators may also include, but are not limited to, (i) significant changes to estimates and assumptions used in the most recent annual or interim impairment testing, (ii) downward revisions to internal forecasts, and the magnitude thereof, (iii) declines in our market capitalization below our book value, and the magnitude and duration of those declines, (iv) a reorganization resulting in a change to our operating segments, and (v) other macroeconomic factors, such as increases in interest rates that may affect the weighted average cost of capital, volatility in the equity and debt markets, or fluctuations in foreign currency exchange rates that may negatively impact our reported results of operations.

Leases

On its inception date, the Company adopted ASC 842 — Leases (“ASC 842”), which requires lessees to record right-of-use (“ROU”) assets and related lease obligations on the balance sheet, as well as disclose key information regarding leasing arrangements.

ROU assets represent our right to use an underlying asset for the lease terms and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Stock-based Compensation

The Company applies ASC No. 718, “Compensation-Stock Compensation,” which requires that share-based payment transactions with employees and nonemployees upon adoption of ASU 2018-07, be measured based on the grant date fair value of the equity instrument and recognized as compensation expense over the requisite service period, with a corresponding addition to equity. Under this method, compensation cost related to employee share options or similar equity instruments is measured at the grant date based on the fair value of the award and is recognized over the period during which an employee is required to provide service in exchange for the award, which generally is the vesting period. In addition to the requisite service period, the Company also evaluates the performance condition and market condition under ASC 718-10-20. For an award which contains both a performance and a market condition, and where both conditions must be satisfied for the award to vest, the market condition is incorporated into the fair value of the award, and that fair value is recognized over the employee’s requisite service period or nonemployee’s vesting period if it is probable the performance condition will be met. If the performance condition is ultimately not met, compensation cost related to the award should not be recognized (or should be reversed) because the vesting condition in the award has not been satisfied.

The Company will recognize forfeitures of such equity-based compensation as they occur.

Segment Reporting

The Company uses the management approach in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker for making operating decisions, allocating resources and assessing performance as the source for determining the Company’s reportable segments. During the three months ended December 31, 2025 and 2024, the Chief Executive Officer has been identified as the chief operating decision maker. The Company’s chief operating decision maker regularly reviews consolidated assets and consolidated operating results prepared under U.S. GAAP for the enterprise as a whole when making decisions about allocating resources and assessing performance of the Company. Consequently, management has determined that the Company only has one operating segment as defined under ASC 280-10-50.

Income taxes

The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their perspective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized.

As a result of the implementation of certain provisions of ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting and disclosure for uncertainty in tax position, as defined, ASC 740 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes. The Company has adopted the provisions of ASC 740 since inception and has analyzed filing positions in each of the federal and state jurisdictions where the Company is required to file income tax returns, as well as open tax years in such jurisdictions. The Company has identified the U.S. federal jurisdiction, and the states of Texas and California, as its “major” tax jurisdictions. However, the Company has certain tax attribute carryforwards which will remain subject to review and adjustment by the relevant tax authorities until the statute of limitations closes with respect to the year in which such attributes are utilized.

The Company believes that its income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. The Company’s policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes.

Commitments and contingencies

In the ordinary course of business, the Company is subject to certain contingencies, including legal proceedings and claims arising out of the business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes its liability for such contingency if it determines it is probable that a loss has occurred and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and specific facts and circumstances of each matter.

Earnings per share

Basic earnings per share are computed by dividing net income attributable to holders of common stock by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share reflect the potential dilution that could occur if securities to issue common stock were exercised.

Recently issued but not yet adopted accounting pronouncements

In July 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. The legislation includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Act and Jobs Act, modifications to the international tax framework, and the restoration of favorable business tax provisions, such as 100% bonus depreciation and the business interest expense limitation, among others. The legislation contains multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. While we are continuing to evaluate the full impact of the legislation, we do not expect the OBBBA to have a material effect on our fiscal 2025 effective tax rate.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new guidance requires enhanced disclosures about income tax expenses. The Company is required to adopt this guidance in the first quarter of the fiscal year 2026. Early adoption is permitted on a prospective basis. We are currently evaluating the impact of this ASU on our annual income tax disclosures.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new guidance requires enhanced disclosures about significant segment expenses. The Company is required to adopt this guidance for fiscal years beginning after December 15, 2023, and for interim period reporting beginning after December 15, 2024 on a retrospective basis. Early adoption is permitted. The Company adopted this guidance in the first quarter of fiscal year 2025. The Company does not expect the adoption of this standard to have a material impact on the consolidated financial statements.

In June 2022, FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this ASU clarify the guidance in ASC 820 on the fair value measurement of an equity security that is subject to a contractual sale restriction and require specific disclosures related to such an equity security. This standard is effective for fiscal years beginning after December 15, 2024. The Company does not expect the adoption of this standard to have a material impact on the consolidated financial statements.

The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

Subsequent events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the consolidated financial statements are available to be issued . Material subsequent events that required recognition or additional disclosure in the consolidated financial statements are presented.

Note 3 — Inventories

As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, inventories consisted of the following:

Schedule of inventories

	June 30, 2025 (unaudited)		September 30, 2024
	December 31, 2025		September 30, 2025
Merchandise inventory	$	2,058,800	$	-
	(unaudited)
Total	$	2,058,800	$	-
Merchandise inventory	$	2,021,409	$	2,107,000
Total	$	2,021,409	$	2,107,000

~~As of June 30, 2025 and September 30, 2024, there was no allowance for obsolescence recorded.~~12

11As of December 31, 2025 and September 30, 2025, there was no allowance for obsolescence recorded.

Note 4 — Prepayments and other current assets

As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, prepayments and other current assets consisted of the following:

	June 30, 2025 (unaudited)		September 30, 2024
	December 31, 2025		September 30, 2025
Prepaid marketing and promotional services	$	40,000	$	-
	(unaudited)
Prepaid for software development		125,000		-
Loan and Interest receivable	$	4,957,096	$	916,164
Prepaid insurance		-		35,172
Receivable from sales of equity investment		350,100		350,100
Prepaid for consulting services		96,528		-
Advance to suppliers		-		157,250
Loan receivable		500,000		-
Prepaid rent		92,000		48,000
Receivable from sales of equity investment		525,100		-
Prepaid insurance		-		34,028
Prepaid rent		24,000		-
Prepaid for legal fee		24,649		24,649
Deposits		24,000		-24,000
Other prepayments and current assets		52,848		30,625
Advance to other service providers		517,500		-
Total	$	1,387,476	$	65,797
Other prepayments and current assets		-		13,250
Total	$	5,965,345	$	1,567,441

On ~~March~~February 28, 2025, the Company ~~sold~~entered ~~all~~into a loan agreement with HST Trading Limited, providing a principal amount of $500,000 at an annual interest rate of 5%. The loan term is six months, with the ~~membership~~principal and accrued interest itdue ~~owns~~for inrepayment ~~Core~~on ~~Modu~~or ~~LLC~~before February 27, 2026. On August 28, 2025, the Company entered into an Amendment to ~~Strucraft~~Loan ~~Group~~Agreement with HST Trading Limited ~~for~~to extend the loan term from six months to twelve months with end date at February 27, 2026. On August 7, 2025, the Company entered into a ~~total~~loan ~~purchase~~agreement with HST Trading ~~price~~Limited, providing a principal amount of $~~700~~400,000 at an annual interest rate of 5%. The loan term is six months, ~~payable~~with inthe ~~four~~principal ~~equal~~and ~~installments~~accrued ~~(see~~interest ~~Note~~due 6for ~~Equity~~repayment ~~Investments)~~on or before February 7, 2026. As of ~~June 30~~December 31, 2025, the ~~amount~~outstanding ~~due~~balance ~~from~~of ~~Strucraft Group~~loan ~~Limited~~and interest receivable was $~~525~~927,~~100~~507.

On ~~February~~October 282, 2025, the Company entered into a loan agreement with ~~HST~~TORCHLIGHT ~~Trading~~GROUP ~~Limited~~LIMITED, providing a principal amount of $~~500~~2,000 ,000.00 at an annual interest rate of 4.5%. The loan term is ~~six~~twelve months, with the principal and accrued interest due for repayment on or before ~~August~~ 30October 1, ~~2025~~2026. As of ~~June~~December 3031, 2025, the outstanding balance of loan and interest receivable was $~~500~~2,~~000~~022,192.

On December 1, 2025, the Company entered into a loan agreement with Shengshi Chuangtou Co., Limited, providing a principal amount of $2,000,000.00 at an annual interest rate of 4.5%. The loan term is twelve months, with the principal and accrued interest due for repayment on or before November 30, 2026. As of December 31, 2025, the outstanding balance of loan and interest receivable was $2,007,397.

Note 5 — Equity Investments

On October 14, 2024, the Company entered into an equity investment agreement with an individual, securing a 15% ownership interest in Core Modu LLC, and for which the Company does not have the ability to exercise significant influence. The investment totaled $1.4 million. The Company measure investments in equity investments without a readily determinable fair value using a measurement alternative that measures these securities at the cost method minus impairment, if any, plus or minus changes resulting from observable price changes on a non-recurring basis. Gains and losses on these securities are recognized in other income and expenses.

On March 28,2025, the Company entered into a Membership Interest Purchase Agreement with Strucraft Group Limited, pursuant to which the Company sold all of the membership interest it owns in Core Modu LLC, which represents 15% of the outstanding membership interest in Core Modu LLC, for an aggregate purchase price of $700,000.

On May 28, 2025, the Company entered into an equity investment agreement with Aurora Technology Holding Limited (“Aurora”), securing a 16.67% ownership interest in Aurora, and for which the Company does not have the ability to exercise significant influence. The investment totaled $1 million. The Company measure investments in equity investments without a readily determinable fair value using a measurement alternative that measures these securities at the cost method minus impairment, if any, plus or minus changes resulting from observable price changes on a non-recurring basis. Gains and losses on these securities are recognized in other income and expenses.13

On May 28, 2025, the Company entered into an equity investment agreement with Aurora Technology Holding Limited (“Aurora”), securing a 16.67% ownership interest in Aurora, and for which the Company does not have the ability to exercise significant influence. The investment totaled $1 million. The Company measure investments in equity investments without a readily determinable fair value using a measurement alternative that measures these securities at the cost method minus impairment, if any, plus or minus changes resulting from observable price changes on a non-recurring basis. A third-party independent appraiser was engaged to calculate pre-investment fair value of Aurora. Gains and losses on these securities are recognized in other income and expenses.

On August 6, 2025, Lear Group Limited, the subsidiary of the Company, entered into an equity investment agreement with Flower Mouse Network Technology Limited (“Flower”), securing a 15% ownership interest in Flower, and for which the Company does not have the ability to exercise significant influence. The investment totaled $1.2 million. The Company measure investments in equity investments without a readily determinable fair value using a measurement alternative that measures these securities at the cost method minus impairment, if any, plus or minus changes resulting from observable price changes on a non-recurring basis. A third-party independent appraiser was engaged to calculate pre-investment fair value of Flower. Gains and losses on these securities are recognized in other income and expenses.

Note 6 — Goodwill, net

As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, goodwill consisted of the following:

Schedule of goodwill, net

Balance at September 30,2024	$	-
	December 31, 2025			September 30, 2025
Acquisition		3,514
	(unaudited)
Impairment losses		(3,514	)
Goodwill, gross	$	-		$	3,514
Balance at June 30, 2025	$	-
Less: Accumulated impairment loss		-			(3,514	)
Goodwill, net	$	-		$	-

Goodwill of $3,514 consists of $1,597 attributable to the acquisition of Baymax that occurred on December 13, 2024 and $1,917 attributable to the acquisition of Lear that occurred on October 18, 2024. ~~The Company recorded a goodwill impairment charge of $3,514 for the nine months ended June 30, 2025.~~

12For the three months ended December 31, 2025 and 2024, impairment loss amounted to $0 and $3,514, respectively

Note 7 — Other payables and accrued liabilities

As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, ~~other payables~~prepayments and ~~accrued~~other ~~liabilities~~current assets consisted of the following:

	June 30, 2025 (unaudited)		September 30, 2024
	December 31, 2025		September 30, 2025
Other payables and accrued liabilities	$	100,702	$	138,700
	(unaudited)
Share subscription payable		730,000		-
Payable to service providers	$	126,845	$	317,283
Total	$	830,702	$	138,700
State tax payable		-		800
Accrued expenses		1,285		-
Other payables		278		27
Total	$	128,408	$	318,110
Other payables and accrued liabilities	$	128,408	$	318,110

As of June 30, 2025, the Company has other payables of $730,000 due to Aurora Technology Holding Limited, an investee of the Company with 16.67% ownership interest. The $730,000 consists solely of the investment amount payable to Aurora pursuant to the equity investment agreement dated May 28, 2025.

Note 8 — Loans payable

Short-term loans

Short term loan without interest

From June 2023 to August 2023, the Company borrowed short-term loans due on demand without interest, amounting to $230,000 from three individuals for operating purposes. As of ~~June 30~~December 31, 2025 and September 30, ~~2024~~2025, the outstanding loan balances due to these individuals were $50,000 and $50,000, respectively. The balance was presented on the consolidated balance sheet as a short-term loan.

Note 9 — ~~Discontinued~~Standby ~~operations~~Equity Purchase Agreement

On July 4, 2025, the Company entered into the SEPA with the Investors. Pursuant to SEPA, the Company has the right, but not the obligation, to issue and sell, from time to time at the Company’s discretion, up to $6 million of shares of our common stock to the Investors at a price equal to 40%, or a percentage between 20% and 40% as determined by us, of the Minimum Price, or $1.20, subject to specified limitations and conditions, including a $0.5 million minimum per drawdown and a 9.99% beneficial ownership cap per investor. The SEPA has a three-year term and may be terminated earlier by the Company, and the Company expect to use any proceeds for working capital and general corporate purposes. The SEPA, in its entirety, is classified as a derivative liability because it did not meet the equity classification criteria under ASC 815-10, Derivatives and Hedging (“ASC 815-10”). The SEPA derivative is valued based on a scenario-based valuation model utilizing the expected draws, probability of the draws and risk-free rate inputs. The change in the fair value of the derivative is recorded in the Condensed Consolidated Statements of Operations. The SEPA is accounted for as a derivative and is recognized as a liability measured at fair value in accordance with ASC 820. The Company intends to utilize the SEPA to access capital to fund its operations.

A third-party independent appraiser was engaged to calculate the estimated fair value of the SEPA. The estimated fair value of the SEPA liability on September 30, 2025, was $370,546, which was determined using a scenario-based valuation model. The liability was remeasured to its fair value was $370,546 as of September 30, 2025, and is classified within non-current liabilities in the Consolidated Balance Sheets. As the SEPA was terminated by mutual agreement between the Investors and the Company on December 30, 2025, the SEPA liability on December 31, 2025 was $Nil. This remeasurement resulted in the recognition of a loss of $370,546 for the three months ended December 31, 2025, classified as change in fair value of SEPA in the Condensed Consolidated Statement of Operations. Assumptions used in the valuation are described below:

Valuation assumptions:	December 31, 2025		September 30, 2025
Expected draws	$	-	$	3,600,000
Expected probability of draws		-		90	%
Risk-free interest rate		-		1.07	%

The estimated fair value of the liability was determined using a scenario-based valuation model which assigned a probability to a number of different outcomes. The inputs and assumptions utilized in the calculation require management to apply judgment and make estimates including:

(a)	total expected draws of $3,600,000 at September 30, 2025;

(b)	the expected probability of the draws on the SEPA, which the Company estimate based on our expectation of the draws being completed; and

(c)	risk-free interest rate, which was determined by reference to the U.S. Treasury yield curve for time periods commensurate with the expected term of the agreement in relation to the date of the expected draw.

These estimates may be subjective in nature and involve uncertainties and matters of judgment and therefore cannot be determined with exact precision.

Note 10 — Discontinued operations

On March 4, 2025, the Company entered into a Share Purchase Agreement with Architectix Limited, pursuant to which the Company sold all issued and outstanding shares it owns in Inno Metal Studs Corp (“IMSC”) and Inno AI Tech Corp (“AT”) for an aggregate purchase price of $1,000.

On March 28, 2025, the Company entered into a Membership Interest Purchase Agreement with Strucraft Group Limited, pursuant to which the Company sold all the membership interest it owns in Castor Building Tech LLC (“CBT”), which represents 55% of the outstanding membership interest in Castor Building Tech LLC, for an aggregate purchase price of $1,000.

~~In accordance~~On ~~with~~April 8, 2025, the ~~provisions~~Company ofentered ~~ASC~~into ~~205-20,~~a ~~Presentation~~Share ofPurchase ~~Financial~~Agreement ~~Statements,~~with weStrucraft ~~have~~Group ~~separately~~Limited, ~~reported~~pursuant to which the ~~assets~~Company sold all issued and ~~liabilities~~outstanding shares it owns in Inno Disrupts Inc. (“Disrupts”) for an aggregate purchase price of ~~the~~$100. ~~discontinued~~The ~~operations~~Company ofdetermined ~~IMSC,~~that ATDisrupts was not a significant subsidiary, and ~~CBT~~the indisposition of Disrupts did not constitute a strategic shift that would have a major effect on the ~~consolidated~~Company’s ~~balance~~operations ~~sheets~~or financial results. ~~The~~As ~~assets~~a ~~and~~result, ~~liabilities~~the ~~have~~results ~~been~~of ~~reflected~~operations for Disrupts were not reported as discontinued operations inunder the ~~consolidated~~guidance ~~balance~~of ~~sheets~~ASC as205 “Presentation of ~~June~~Financial 30Statements.” The disposition of Disrupts resulted in the recognition of a loss of $26,200 ~~2025~~for ~~and~~the year ended September 30, ~~2024~~2025, ~~and~~classified ~~consist~~as ofloss on investment disposal in the ~~following:~~Consolidated Statement of Operations.

Schedule of Discontinued Operations

	June 30, 2025 (unaudited)		September 30, 2024
Current assets from discontinued operations
Cash and cash equivalent	$	-	$	449,523
Inventories		-		333,074
Prepayments and other current assets		-		363,076
Total current assets from discontinued operations	$	-	$	1,145,673
Non-current assets from discontinued operations
Right-of-use assets	$	-	$	570,295
Property and equipment, net		-		1,300,583
Other non-current assets		-		9,851
Non-current assets from discontinued operations	$	-	$	1,880,729
Current liabilities from discontinued operations
Accounts payable	$	-	$	271,507
Deferred revenue		-		590,260
Other payables and accrued liabilities		-		149,252
Other payables – related party		-		1,000
Operating lease liability – current		-		60,236
Long-term notes payable – current portion		-		51,898
Total current liabilities from discontinued operations	$	-	$	1,124,153
Non-current liabilities from discontinued operations
Notes payable	$	-	$	58,948
Total non-current liabilities from discontinued operations	$	-	$	58,948

In accordance with the provisions of ASC 205-20, we have not included the results of operations from discontinued operations in the results of continuing operations in the consolidated statements of operations. The results of operations from discontinued operations for the three and nine months ended June 30, 2025 and 2024, have been reflected as discontinued operations in the consolidated statements of operations for the three and nine months ended June 30, 2025 and 2024, and consist of the following:

	2025		2024			2025			2024
	For the Three Months Ended June 30,					For the Nine Months Ended June 30,
	2025		2024			2025			2024
Revenue	$	-	$	45,682		$	2,000		$	395,495
Cost of sales		-		25,549			-			404,157
GROSS PROFIT / (LOSS)		-		20,133			2,000			(8,662	)
Selling, general and administrative expenses (exclusive of expenses shown separately below)		-		843,498			188,282			2,255,234
Impairment loss on goodwill		-		-			-			23,911
Bad debt expense		-		-			-			59,935
Depreciation		-		22,405			30,930			65,728
Total operating expenses		-		865,903			219,212			2,404,808
LOSS FROM OPERATIONS		-		(845,770	)		(217,212	)		(2,413,470	)
Interest income (expenses), net		-		(1,922	)		(2,522	)		(22,145	)
Other non-operating income (expense)		-		(33,581	)		23,938			(91,083	)
Total other (expenses) income, net		-		(35,503	)		21,416			(113,228	)
Net loss from discontinued operations		-		(881,273	)		(195,796	)		(2,526,698	)
Non-controlling interest		-		13,821			69,517			(35,395	)
Net loss from discontinued operations to the Company	$	-	$	(895,094	)	$	(265,313	)	$	(2,491,303	)

In accordance with the provisions of ASC 205-20, we have included the net cash provided by discontinued operations in the consolidated statements of cash flows. The net cash provided by discontinued operations in the consolidated statements of cash flows for the nine months ended June 30, 2025 and 2024, consists of the following:

	2025			2024
	For the Nine Months Ended June 30, (unaudited)
	2025			2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss from discontinuing operation	$	(265,313	)	$	(2,491,303	)
Adjustments to reconcile net income to cash used in operating activities:
Non-controlling interest		69,517			-
Loss from settlement					28,796
Depreciation expense		30,930			65,728
Bad debt expense		-			59,935
Non-cash operating lease expense		69,003			163,848
Fixed assets disposal loss		63,035			5,035
Loss from investment disposal		-			23,715
Impairment loss		-			23,911
Change in discontinued operating assets and liabilities:
Accounts receivable		-			10,500
Inventories		-			55,863
Prepayments and other current assets		85,535			5,010,192
Accounts payable		11,798			(640,042	)
Unearned revenue		-			(532,566	)
Operating lease liabilities		(4,282	)		(670,796	)
Other payables and accrued liabilities		(437,889	)		(226,202	)
Note payable		(21,282	)		-
Net cash (used in)/ provided by operating activities by discontinued operations		(398,948	)		886,614
CASH FLOWS FROM INVESTING ACTIVITIES:
Fixed assets additions		(26,853	)		(424,800	)
Purchase of investment in equity investee		-			-
Proceed from fixed assets disposal		-			12,569
Net cash used in investing activities by discontinued operations		(26,853	)		(412,231	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from related parties		-			124,628
Payments to short-term loans		-			(560,000	)
Payment to long-term note		-			(36,825	)
Net cash provided by financing activities		-			(472,197	)
CHANGES IN CASH AND CASH EQUIVALENT	$	(425,801	)	$	2,186

Note 10 — Related party transactions

The Company borrows short term loans without interest from its Former CEO, Mr. Dekui Liu, for operation and cashflow needs from time to time. As of June 30, 2025, the amount due to Mr. Liu was $Nil. As of September 30, 2024, the amount due to Mr. Liu was $1,000.

Starting in December 2022, for operation and cashflow needs, the Company advances funds from Zfounder Organization Inc., (“Zfounder”), one of the Company’s minority shareholders, and Wise Hill Inc., (“Wise Hill”), a company owned by a former shareholder of the Company who also serves as the CEO and Board member of Zfounder. The advanced amounts are non-interest bearing. As of June 30, 2025, and September 30, 2024, the outstanding balance, due to Zfounder and Wise Hill, were $Nil and $Nil, respectively. During the three and nine months ended June 30, 2025, other income of employee lease service from Zfounder was $Nil and $34,000, respectively. Zfounder was a principal shareholder of the Company as of September 30, 2024. In October 2024, Zfounder sold most of its shares of the Company to third parties, after which it became a minority shareholder of the Company, so both Zfounder and Wise Hill are no longer considered as related parties of the Company.

In March 2023, the Company entered into an agreement with Vision Opportunity Fund LP, a Florida limited partnership partially owned by a minority shareholder of the Company, who also serves as the CEO and Board member of Zfounder. In August 2023, all rights, obligations and interests under the agreement were subsequently assigned by Vision Opportunity Fund LP to its general partner, New Vision 101 LLC (“Vision 101”). Pursuant to the agreement, the Company agreed to provide supplies and act as project developer for an amount equal to $15,875,800 plus applicable taxes. As of June 30, 2025, amount of $244,185 has been received and recorded as deferred revenue, and $Nil amount of revenue has been recognized. As Zfounder is now a minority shareholder of the Company and the Company sold all issued and outstanding shares it owns in Inno Metal Studs Corp on March 4, 2025, Vision 101 is no longer considered as related parties of the Company.

OnIn ~~October~~accordance ~~14,~~with ~~2024,~~ the ~~Company~~provisions ~~entered~~of ~~into~~ASC an205-20, ~~equity~~we ~~investment~~have ~~agreement~~not ~~with~~included anthe ~~individual,~~results ~~securing~~of aoperations ~~15%~~from ~~ownership~~discontinued ~~interest~~operations in ~~Core Modu LLC. During~~ the ~~three~~results of ~~and~~continuing ~~nine~~operations ~~months~~in ~~ended~~the ~~June~~consolidated ~~30,~~statements ~~2025,~~of ~~other~~operations. ~~income~~The results of ~~employee~~operations ~~lease service~~ from ~~Core~~discontinued ~~Modu~~operations ~~was~~for ~~$Nil and $15,000,~~the ~~respectively.~~three Onmonths ~~March~~ended 28December 31, 2025, ~~the~~and ~~Company~~2024, ~~agreed~~have tobeen ~~sell~~reflected ~~all~~as ofdiscontinued ~~the~~operations ~~membership interest it owns~~ in ~~Core~~the ~~Modu~~condensed ~~LLC,~~consolidated ~~which represents~~statements ~~15%~~ of ~~the~~operations ~~outstanding~~for ~~membership~~the ~~interest~~three inmonths ~~Core~~ended ~~Modu~~December ~~LLC.~~31, ~~Core~~2025 ~~Modu~~and ~~LLC~~2024, isand noconsist ~~longer considered as related parties~~ of the ~~Company.~~following:

~~The~~ Schedule ~~Company purchases prefab home, materials and supplies, including design services from Baicheng Trading LLC (“Baicheng”), a company with a director related to the former Chairwoman. As~~ of ~~June~~discontinued 30, 2025, and September 30, 2024, the outstanding balance of prepayments to Baicheng was $Nil and $225,511, respectively. As the former Chairwoman resigned from her position of the Company in October 2024, Baicheng is no longer considered as a related party of the Company.operations


	For the Three months Ended December 31,
	2025		2024
Revenue	$	-	$	2,000

Cost of sales		-		-
GROSS PROFIT / (LOSS)		-		2,000

Selling, general and administrative expenses (exclusive of expenses shown separately below)		-		107,987
Depreciation		-		20,209
Total operating expenses		-		128,196

LOSS FROM OPERATIONS		-		(126,196	)

Interest income (expenses), net		-		(1,763	)
Other non-operating income (expense)		-		(19,710	)
Total other (expenses) income, net		-		(21,473	)
Net loss from discontinued operations		-		(147,669	)

Non-controlling interest		-		(1,712	)

Net loss from discontinued operations to the Company	$	-	$	(145,957	)

~~Note~~In 11accordance —with ~~Equity~~the provisions of ASC 205-20, we have included the net cash provided by discontinued operations in the consolidated statements of cash flows. The net cash provided by discontinued operations in the consolidated statements of cash flows for the three months ended December 31, 2025 and 2024, consists of the following:


	For the Three Months Ended December 31,
	2025		2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss from discontinuing operation	$	-	$	(145,957	)
Adjustments to reconcile net income to cash used in operating activities:
Non-controlling interest		-		(1,712	)
Depreciation expense		-		20,209
Non-cash operating lease expense		-		43,782
Fixed assets disposal loss		-		63,035
Prepayments and other current assets		-		55,625
Accounts payable		-		7,465
Operating lease liabilities		-		(6,299	)
Other payables and accrued liabilities		-		(444,599	)
Note payable		-		(12,719	)
Net cash used in operating activities by discontinued operations		-		(421,170	)
CASH FLOWS FROM INVESTING ACTIVITIES:		-
Fixed assets additions		-		(26,854	)
Net cash used in investing activities by discontinued operations		-		(26,854	)
CHANGES IN CASH AND CASH EQUIVALENT	$	-	$	(448,024	)

Note 11 — Related party transactions

On October 14, 2024, the Company entered into an equity investment agreement with an individual, securing a 15% ownership interest in Core Modu LLC. During the three months ended December 31, 2024, other income of employee lease service from Core Modu was $15,000. On March 28, 2025, the Company agreed to sell all of the membership interest it owns in Core Modu LLC, which represents 15% of the outstanding membership interest in Core Modu LLC. Core Modu LLC is no longer considered as related parties of the Company.

Note 12 — Equity

The Company was incorporated in Texas on September 8, 2021. The total authorized shares of capital stock were 200,000,000 shares without par value.

On November 30, 2022, the Company effected a forward stock split (the “Stock Split”) of the Company’s issued and outstanding shares of the common stock at a split ratio of 2-for-1. Further on July 24, 2023, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of the common stock at a split ratio of 1-for-2 such that every holder of common stock of the Company shall receive one share of common stock for every two shares of common stock held and to reduce the number of authorized shares of common stock from 200,000,000 to 100,000,000. Shortly after the Reverse Stock Split, the Board of Directors of the Company approved issuance of additional shares to preserve the original purchase price per share of the shares sold in the period from February 1 to June 30, 2023.

On October 9, 2024, the Company completed a 1-for-10 reverse stock split of its issued and outstanding common stock, no par value, (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each share of common stock issued and outstanding immediately prior to October 9, 2024 were ~~automatically~~ converted into one-tenth (1/10) of a share of common stock. The Common Stock began trading on a Reverse Stock Split-adjusted basis on the Nasdaq Capital Market on October 10, 2024. The trading symbols for the Common Stock ~~remains~~ remains “INHD”. The Reverse Stock Split did not reduce the number of authorized shares of Common Stock and did not change the par value of the Common Stock. The Reverse Stock Split affected all stockholders uniformly. Except to the extent that the Reverse Stock Split resulted in the stockholders’ fractional shares being rounded up, no other effects affect stockholder’s ownership percentage of the Company’s shares of Common Stock. ~~199,787 fractional shares were issued in connection with the Reverse Stock Split. All share numbers of the Company’s Common Stock are stated on a post-split basis.~~

AsOn ofDecember ~~March 31~~22, 2025, the Company completed a 1-for-24 reverse stock split of its issued and ~~September~~outstanding 30common stock, ~~2024~~no par value, ~~after~~(the “Reverse ~~giving~~Stock ~~effect~~Split”). toAs a result of the Reverse Stock Split, each share of common stock ~~splits~~issued and outstanding immediately prior to December 22, 2025 were converted into one twenty-fourth (1/24) of a share of common stock. The Reverse Stock Split did not reduce the ~~outstanding~~number of authorized shares of Common Stock, ~~there~~and ~~were~~did not change the par value of the Common Stock. The Reverse Stock ~~4,209,127~~Split ~~and~~affected 2all stockholders uniformly. Except to the extent that the Reverse Stock Split resulted in the stockholders’ fractional shares being rounded up on the participant level,~~279,960~~ no other effects affect stockholder’s ownership percentage of the Company’s shares of Common Stock. 37 fractional shares were issued ~~and~~in ~~outstanding,~~connection ~~respectively.~~with ~~The~~the ~~total~~Reverse ~~authorized~~Stock ~~number~~Split. ofAll ~~shares~~share numbers of ~~capital~~the Company’s ~~stock~~Common ~~was~~Stock ~~100,000,000~~are ~~shares~~stated ~~without~~on ~~par~~a ~~value~~post-split basis.

InAs of December ~~2022~~31, ~~The~~2025 ~~Company~~and ~~issued~~September 1430,~~286~~ 2025, after giving effect to the stock splits of the outstanding shares of ~~its~~Common ~~common~~Stock, ~~stock~~there were at7,081,224 aand ~~price~~539,520 shares of ~~$35~~Common Stock issued and outstanding, respectively.0 ~~per~~The ~~share~~total toauthorized annumber ~~accredited~~of ~~investor~~shares ~~for~~of ~~$500~~capital stock was 100,000 in,000 ~~cash~~shares without par value.

In ~~February~~December ~~2023~~2022, The Company issued 2596 shares (14,~~703~~286 shares pre–Reverse Stock Split) of its common stock at a price of $~~37.0~~839 per share to an accredited investor for $~~100~~500,000 in cash.

In ~~March~~February 2023, The Company issued 7113 shares (2,~~895~~703 shares pre–Reverse Stock Split) of its common stock at a price of $~~38.0~~885 per share to an accredited investor for $~~300~~100,000 in cash.

OnIn ~~June~~March ~~20,~~ 2023, ~~the~~The Company issued ~~1,316~~329 shares ~~of its common stock for a total value of $50~~(7,~~000~~895 ~~for~~shares ~~services~~pre–Reverse toStock beSplit) ~~rendered during next twelve months by the immediate relative~~ of ~~the Company’s Chief Financial Officer. On June 20, 2023, the Company issued 1,973 shares of~~ its common stock ~~for~~at a ~~total~~price ~~value~~ of $~~75,000~~912 ~~for services to be rendered during next twelve months by one nonemployee contractor. These shares were valued at $38.0~~ per share~~, which was the per share price for the most recent sale of the Company’s capital stock~~ to an accredited ~~investors.~~investor ~~On January 1, 2024, the Company issued 5,000 shares of its common stock~~ for ~~a total value of~~ $72300,000 ~~for~~in ~~services to be rendered during next twelve months by one advisor firm~~cash.

16On June 20, 2023, the Company issued 55 shares (1,316 shares pre-Reverse Stock Split) of its common stock for a total value of $50,000 for services to be rendered during next twelve months by the immediate relative of the Company’s Chief Financial Officer. On June 20, 2023, the Company issued 83 shares (1,973 shares pre-Reverse Stock Split) of its common stock for a total value of $75,000 for services to be rendered during next twelve months by one nonemployee contractor. These shares were valued at $904 per share, which was the per share price for the most recent sale of the Company’s capital stock to accredited investors. On January 1, 2024, the Company issued 209 shares (5,000 shares pre-Reverse Stock Split) of its common stock for a total value of $72,000 for services to be rendered during next twelve months by one advisor firm.

The registration statement for the Company’s Initial Public Offering (the “Offering”) was declared effective on November 9, 2023. The Common Stock commenced trading on the Nasdaq Capital Market (the “Nasdaq”) on December 14, 2023, under the symbol “INHD.” The closing of the Offering took place on December 18, 2023. On December 18, 2023, in connection with the closing of the initial public offering of 250,000 shares (“the Shares”) of its common stock, no par value, the Company adopted its Amended and Restated Bylaws, effective the same day. In connection with the Offering of the Shares at an offering price of $40.0 per share, the Company also granted the underwriters an option exercisable for 45-days to purchase up to 37,500 shares of Common Stock as the Public Offering Price, less the underwriting discount to cover-over allotment. Additionally, the Company also issued warrants to the underwriters to purchase up to 20,125 shares of Common Stock at an exercise price of $48.0 per share, subject to adjustment as set forth in the warrants, exercisable from June 18, 2024 and valid until December 18, 2028. On March 1, 2024, the Company entered into a warrant assumption agreement with the underwriter to assume those certain underwriter’s warrants for the purchase an aggregate amount of 20,125 shares of the Company’s common stock in connection with the Company’s initial public offering. Pursuant to the warrant assumption agreement, the Company paid an aggregate amount of $13,000 for the assumption of the Warrants. The paid amount of $13,000 was recorded to reduce Additional Paid-in Capital. As of September 30, 2024, the Warrants are no longer outstanding.17

The registration statement for the Company’s Initial Public Offering (the “Offering”) was declared effective on November 9, 2023. The Common Stock commenced trading on the Nasdaq Capital Market (the “Nasdaq”) on December 14, 2023, under the symbol “INHD.” The closing of the Offering took place on December 18, 2023. On December 18, 2023, in connection with the closing of the initial public offering of 10,417 shares (“the Shares”) (250,000 shares pre-Reverse Stock Split) of its common stock, no par value, the Company adopted its Amended and Restated Bylaws, effective the same day. In connection with the Offering of the Shares at an offering price of $960 per share, the Company also granted the underwriters an option exercisable for 45-days to purchase up to 1,563 shares (37,500 shares pre-Reverse Stock Split) of Common Stock as the Public Offering Price, less the underwriting discount to cover-over allotment. Additionally, the Company also issued warrants to the underwriters to purchase up to 839 shares (20,125 shares pre-Reverse Stock Split) of Common Stock at an exercise price of $1,152 per share, subject to adjustment as set forth in the warrants, exercisable from June 18, 2024 and valid until December 18, 2028. On March 1, 2024, the Company entered into a warrant assumption agreement with the underwriter to assume those certain underwriter’s warrants for the purchase an aggregate amount of 839 shares (20,125 shares pre-Reverse Stock Split) of the Company’s common stock in connection with the Company’s initial public offering. Pursuant to the warrant assumption agreement, the Company paid an aggregate amount of $13,000 for the assumption of the Warrants. The paid amount of $13,000 was recorded to reduce Additional Paid-in Capital. As of December 31, 2025, the Warrants are no longer outstanding.

The total gross proceeds from the Offering were $10,000,000, before deducting underwriting discounts and other offering expenses associated with the Offering payable by the Company or paid by the Company. Transaction costs related to the offering amounted to $2,140,466, consisting of $700,000 of underwriting fees, $345,876 of underwriting related expenses, $595,000 of legal fees and $499,590 of other costs. Of the total transaction cost of $2,140,466, $590,466 in transaction costs were incurred and paid by the company before the closing date. These costs were recorded as deferred offering costs and were offset to equity upon the completion of the IPO. $8,450,000 total net cash from the Offering has been received by the Company on December 19, 2023.

On October 31, 2024, the Company entered into a securities purchase agreement with certain investors, providing for the sale and issuance of 20,834 shares (500,000 shares pre-Reverse Stock Split) of the Company’s common stock, no par value, for an aggregate purchase price of $2,000,000 at $~~4.00~~96 per share (the “October 2024 Private Placement”). The offering closed on November 6, 2024.

On November 13, 2024, the Company entered into a securities purchase agreement with nine non-U.S. investors, pursuant to which the Company agreed to issue and sell in a private placement offering (the “November 2024 Private Placement”) an aggregate of 30,382 shares (729,167 shares pre-Reverse Stock Split) of common stock, no par value, at a purchase price per share of $~~4.80~~115, for gross proceeds of approximately $3.5 million, of which proceeds will be used for working capital and other general corporate purposes. The offering closed on December 13, 2024.

On December 11, 2024, the Company entered into a securities purchase agreement with nine non-U.S. investors, pursuant to which the Company agreed to issue and sell in a private placement offering (the “December 2024 Private Placement”) an aggregate of 29,167 shares (700,000 shares pre-Reverse Stock Split) of common stock, no par value, at a purchase price per share of $~~2.50~~60, for gross proceeds of approximately $1.75 million, of which proceeds will be used for working capital and other general corporate purposes. The offering closed on December 23, 2024.

On January 16, 2025, pursuant to the Omnibus Incentive Plan, the Company granted 6,250 shares (150,000 shares ofpre-Reverse Stock Split) of our common stock to our Chief Executive Officer Ding Wei, and 2,140 shares (51,355 shares pre-Reverse Stock Split) of our common stock to our Chief Financial Officer Mengshu Shao.

On May 28, 2025, pursuant to 2025 Omnibus Incentive Plan, the Company granted 36,667 shares (880,000 shares ofpre-Reverse Stock Split) of its common stock to the Company’s employees.

On January 27, 2025, the Company entered into a Standby Equity Purchase Agreement (the “January SEPA”) with certain investors effective as of January 28, 2025. Pursuant to January SEPA, the Company has the right to issue and sell to the investors, from time to time, up to $15 million worth of shares of the Company’s common stock, no par value per share, subject to the terms and conditions specified in the January SEPA. On June 20,2025, the Company issued and sold an aggregate of 1,400,000 shares (the “January 2025 SEPA Shares”) of its common stock at a purchase price per share of $0.75, pursuant to January SEPA. As of June 30, 2025, $756,250 of the subscription amount has been received and the subscription receivable was $293,750.18

~~Note~~On 12January —27, ~~Concentration~~2025, the Company entered into a Standby Equity Purchase Agreement (the “January SEPA”) with certain investors effective as of ~~risk~~January 28, 2025. Pursuant to January SEPA, the Company has the right to issue and sell to the investors, from time to time, up to $15 million worth of shares of the Company’s common stock, no par value per share, subject to the terms and conditions specified in the January SEPA. On June 20,2025, the Company issued and sold an aggregate of 58,334 shares (1,400,000 shares pre-Reverse Stock Split) (the “January 2025 SEPA Shares”) of its common stock at a purchase price per share of $18, pursuant to January SEPA.

On July 4, 2025, the Company entered into the Standby Equity Purchase Agreement (the “July SEPA”) with the Investors. Pursuant to July SEPA, the Company has the right to issue and sell to the investors, from time to time, up to $6 million worth of shares of the Company’s common stock, no par value per share, subject to the terms and conditions specified in the July SEPA. On August 27,2025, the Company issued and sold an aggregate of 133,334 shares (3,200,000 shares pre-Reverse Stock Split) of its common stock at a purchase price per share of $12, pursuant to July SEPA.

On September 10, 2025, the Company entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company offered, in a registered direct offering, 50,000 shares (1,200,000 shares pre-Reverse Stock Split) of its common stock, at a purchase price of $86 per share and pre-funded warrants to purchase up to 33,334 shares (800,000 shares pre-Reverse Stock Split) of common stock, at a purchase price of $86.3998 per pre-funded warrant (equal to $86.4 minus the exercise price of $0.0002 per pre-funded warrant). The closing of the offering occurred on September 11, 2025. The Company received net proceeds of approximately $6.69 million from the offering, after deducting the estimated offering expenses payable by the Company, including the placement agent fees. As of September 26, 2025, 799,998 pre-funded warrants were exercised for the issuance of 33,334 shares (799,998 shares pre-Reverse Stock Split) of the Company’s common stock.

On November 12, 2025, the Company entered into a sales agreement (the “Sales Agreement”) with Aegis Capital Corp. (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time, to or through the Sales Agent, shares of the Company’s common stock, with no par value, having an aggregate offering price of up to $50.0 million (the “Placement Shares”). From November 12, 2025 to December 15, 2025, the Company issued an aggregate of 3,541,667 shares (85,000,000 shares pre-Reverse Stock Split) of Common Stock for the gross proceeds of approximately $28 million through the Sales Agent pursuant to the Sales Agreement.

On December 26, 2025 the Company entered into a securities purchase agreement with each of ten (10) non-U.S. investors relating to the issuance and sale of an aggregate of 3,000,000 shares of the Company’s common stock with no par value, at the market price of $1.31 per share, for an aggregate purchase price of $3,930,000.

Note 13 — Concentration of risk

Credit risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.

As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, $14,~~239~~386,~~570~~033 and $1420,~~526,661,~~086 respectively, were deposited with various major financial institutions in the United States. Accounts at each institution in the United States are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000. As of ~~June~~December 31, 2025 and September 30, 2025, the Company had deposits in excess of the FDIC insurance limit with two financial institutions in the United States with $ ~~976~~4,~~997~~122,710 ~~uninsured.~~and ~~As of September 30~~$156,849 ~~2024~~uninsured, ~~the Company did not have deposit in excess of the FDIC insurance limit~~respectively.

Accounts receivable are typically unsecured and derived from revenue earned from customers, thereby exposing the Company to credit risk. The risk is mitigated by the Company’s assessment of its customers’ creditworthiness and its ongoing monitoring of outstanding balances.

Customer and vendor concentration risk

For the three ~~and nine~~ months ended ~~June~~December 3031, 2025, ~~two~~three customers accounted for 100% ~~and 76%~~ of the Company’s total revenues~~, respectively~~. For the three ~~and nine~~ months ended ~~June~~December 3031, 2024, ~~one~~two ~~and four~~ customers accounted for ~~98% and~~ 100% of the Company’s total revenues~~, respectively~~. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, $Nil outstanding of accounts receivable.

17For the three months ended December 31, 2025, two suppliers accounted for 100% of the Company’s total purchases. For the three months ended December 31, 2024, two suppliers accounted for 100% of the Company’s total purchases. As of December 31, 2025 and September 30, 2025, $Nil outstanding of accounts payable.

~~For~~Note ~~the~~14 ~~three~~— ~~and~~Commitments ~~nine months ended June 30, 2025, two suppliers accounted for 100% of the Company’s total purchases. For the three~~ and nine months ended June 30, 2024, two suppliers accounted for 100% and 58% of the Company’s total purchases, respectively. As of June 30, 2025, $Nil outstanding of accounts payable. As of September 30, 2024, accounts payable to two suppliers accounted for 51% of the Company’s total accounts payable.contingencies

Note 13 — Commitments and contingencies

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business.

OnIn ~~July~~December ~~23,~~ 2024, a former shareholder of the Company ~~reached~~(the “Shareholder”) filed a ~~settlement~~complaint against the Company and other entities and individuals affiliated with athe ~~subcontractor’s~~Company ~~customer~~in ~~for~~the Orange County Superior Court of California, alleging financial losses related to his investment in entities affiliated with the Company. The Shareholder claims he invested approximately $73500,000 and later sold his shares for $7 million but alleges that, absent interference by an initial public offering organizer, the shares could have been sold for $9 million. Accordingly, he claims to have lost a potential gain of $2 million. In September 2025, the Shareholder submitted a request to the Orange County Superior Court of California for dismissal of the compliant without prejudice and the compliant was dismissed accordingly. The Company filed a memorandum of costs in October 2025 for a claim for attorney fees, and the Shareholder then filed a motion to tax the memorandum of costs filed by the Company. The hearing of the motion has been scheduled for April 2026 which will determine how much, if any, the probability of the Company will be reimbursed for its attorney fees.

In December 2024, a former shareholder of the Company (the “Shareholder”) filed a complaint against the Company and other entities and individuals affiliated with the Company in the Orange County Superior Court of California, alleging financial losses related to his investment in entities affiliated with the Company. The Shareholder claims he invested approximately $500,000 and later sold his shares for $7 million but alleges that, absent interference by an initial public offering organizer, the shares could have been sold for $9 million. Accordingly, he claims to have lost a potential gain of $2 million. The case is currently in the pre-answer stage. The Company has filed a petition to compel arbitration, seeking to move the dispute to arbitration in Texas. A demurrer has also been filed on behalf of one of the individual defendants represented by the Company’s counsel, challenging the legal sufficiency of the complaint. The Company believes that the complaint is without any merit and intends to defend the matter vigorously. Since the case is currently in the pre-answer stage, an estimate of the possible loss or range of loss cannot be made at this moment.

Except as set forth above, we are not currently a party to any legal proceeding that we believe would adversely affect our financial position, results of operations, or cash flows and are not aware of any material legal proceedings contemplated by governmental authorities.

Note 1415 — Segment Information

Reportable Segments

The Company operates as a ~~single~~1single reportable segment, which is consistent with how the Chief Operating Decision Maker (“CODM”), the Chief Executive Officer, allocates resources and assesses performance. The Company’s operations are centralized and integrated, with financial results reviewed and managed on a consolidated basis. Accordingly, management has determined that the Company has one reportable segment under ASC Topic 280, Segment Reporting.

Measure of Segment Profit or Loss

The CODM reviews financial information on a consolidated basis, using Net Income as the primary measure of segment performance to monitor budget versus actual results and decide where to allocate and invest additional resources to achieve continued growth. Net Income is defined as revenue less cost of goods sold and operating expenses, and other segment items (including interest income, interest expense, other income and other expenses), and income taxes.

Significant Segment Expense Categories Provided to the CODM

The CODM regularly receives and reviews the following expense categories, which are included in the segment’s measure of profit or loss.

Schedule of ~~Segment~~segment ~~Information~~ information

	2025			2024			2025			2024
	For the Three Months Ended December 31,
	For the Three Months Ended June 30,						For the Nine Months Ended June 30,
	2025			2024
	2025			2024			2025			2024
Revenues	$	1,456,481		$	196,000
Revenues	$	1,086,250		$	-		$	1,760,350		$	-
Cost of revenues		1,382,346			180,000
Cost of revenues		1,102,300			-			1,718,900			-
Sales and marketing expenses
Sales and marketing expenses
– Marketing service expenses		40,000			-
– Marketing service expenses		60,000			-			80,000			20,925
General and administrative expenses
General and administrative expenses
– Payroll and stock-based compensation expenses		67,201			29,500
– Payroll and stock-based compensation expenses		1,186,200			20,833			2,307,751			83,333
– Professional service expenses		398,474			357,964
– Professional service expenses		263,065			85,516			894,916			317,116
– Office related expenses		18,272			83,128
– Office related expenses		18,325			82,318			113,818			239,723
– Lease expenses		36,000
– Lease expenses		17,000			-			29,500			-
– Other expenses		56
– Travel expenses		-			-			-			3,568
Other segment expenses (income), net		(457,250	)		3,148
Other segment expenses (income), net		(14,352	)		(19,059	)		2,120,634			(230,091	)
Income tax expense		-			-
Income tax expense		-			-			-			800
Net loss from continuing operations	$	(28,618	)	$	(457,740	)
Net loss from continuing operations	$	(1,546,288	)	$	(169,608	)	$	(5,505,169	)	$	(435,374	)
Net loss from discontinued operations		-			(147,669	)
Net loss from discontinued operations		-			(881,273	)		(195,796	)		(2,526,698	)

The following table presents revenues by geographic area based on the sales location of our products:

Schedule of ~~Revenues~~revenues by ~~Geographic~~geographic ~~Area~~area

	2025		2024		2025		2024
	For the Three Months Ended December 31,
	For the Three Months Ended June 30,				For the Nine Months Ended June 30,
	2025		2024
	2025		2024		2025		2024
Hong Kong	$	1,456,481	$	196,000
Hong Kong	$	1,086,250	$	-	$	1,760,350	$	-
Total revenue	$	1,456,481	$	196,000
Total revenue		1,086,250		-		1,760,350		-

Note 16 15 — Stock-based compensation

The Company recorded stock-based compensation expense as follows:

Schedule of ~~Stock~~stock-based ~~Compensation~~compensation ~~Expense~~expense

	2025		2024		2025		2024
	For the Three Months Ended December 31,
	For the Three Months Ended June 30,				For the Nine Months Ended June 30,
	2025		2024
	2025		2024		2025		2024
Restricted stock:
Restricted stock:
– Stock awards	$	-	$	9,000
– Stock awards		1,135,200		20,833		2,185,205		83,333
Total	$	-	$	9,000
Total		1,135,200		20,833		2,185,205		83,333

~~On January 16, 2025, pursuant to the Omnibus Incentive~~Note ~~Plan,~~17 ~~the~~— ~~Company~~Basic ~~granted 150,000 shares of our common stock to our Chief Executive Officer Ding Wei,~~ and ~~51,355~~diluted ~~shares~~net ofloss our common stock to our Chief Financial Officer Mengshu Shao. The stock grant does not have vesting period. The price of the granted stocks is based on the closing price of the Company’s stock on grant date, which is $5.17 per share.

~~On May 28, 2025, pursuant to 2025 Omnibus Incentive~~Basic ~~Plan,~~loss ~~the~~per ~~Company~~share ~~granted~~and ~~880,000~~diluted ~~shares~~loss ofper ~~its~~share ~~common~~have ~~stock~~been tocalculated ~~the~~in ~~Company’s~~accordance ~~employees.~~with ~~The~~ASC ~~stock~~260 ~~grant~~on ~~does~~computation ~~not have vesting period. The price~~ of ~~the~~earnings ~~granted~~per ~~stocks~~share isfor ~~based on~~ the three ~~closing~~months ~~price~~ended ofDecember ~~the Company’s stock on grant date~~31, ~~which~~2025 isand ~~$1.29~~2024 ~~per share.~~as follows:

~~Note~~Potential 16dilutive —securities ~~Subsequent~~are ~~events~~excluded from the calculation of diluted EPS in loss periods as their effect would be anti-dilutive.

As Schedule of ~~June~~basic 30, 2025, the Company is involved in a litigation related to alleged fund transfers. A plaintiff claims that one of the Company’s subcontractors misappropriated over $1.3 million from a construction project in 2020-2021, transferring the funds to the company instead of fulfilling a judgment. On July 9, 2025, the Company entered into a Settlement and ~~Release~~diluted ~~Agreement~~net ~~(the~~loss ~~“Settlement~~per and Release Agreement”) with the plaintiff that for a total settlement payment of $75,000 (the “Settlement Payment”), the plaintiff permanently releases, acquits, and discharges Inno Holdings Inc. and its affiliates from all claims, liabilities, and obligations of any kind. This includes all known and unknown claims up to the Settlement and Release Agreement’s effective date, specifically those related to the Lawsuit or any federal, state, or local laws. The Settlement Payment has been paid to the plaintiff on July 15, 2025.share

On July 21, 2025, the Company has fully paid the investment amount to Aurora Technology Holding Limited pursuant to the equity investment agreement dated May 28, 2025. The share subscription payable of $730,000 as of June 30, 2025 has been cleared and the balance is zero as of the date of this report.


	For the Three Months Ended December 31,
	2025			2024
Statement of Operations Summary Information:
Net loss from continued operation	$	(28,618	)	$	(457,740	)
Weighted- average common shares outstanding – basic and diluted		2,081,643			115,934
Net loss per share, basic and diluted from continued operation	$	(0.01	)	$	(3.95	)
Net loss from discontinued operation	$	-		$	(145,957	)
Weighted- average common shares outstanding – basic and diluted		-			115,934
Net loss per share, basic and diluted from continued operation	$	-		$	(1.26	)

18As of December 31, 2025 and September 30, 2025, there were no potentially dilutive shares.

Note 18 — Subsequent events

On January 5, 2026, the Company incorporated a new wholly-owned subsidiary, Equicap Holdings Limited, in the British Virgin Islands.

The Company entered into a securities purchase agreement on December 26, 2025 with each of ten non-U.S. investors relating to the issuance and sale of an aggregate of 3,000,000 shares of the Company’s common stock with no par value, at the market price of $1.31 per share, for an aggregate purchase price of $3,930,000 (the “December 2025 Offering”). On January 6, 2026, the Company closed the December 2025 Offering.

On January 16, 2026, the Company entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the investors (the “January 2026 Offering”), an aggregate of 1,332,000 shares of its common stock, no par value, at a purchase price per share of $0.55. The January 2026 Offering closed on January 21, 2026 and the Company received gross proceeds of $732,600.

On January 20, 2026, the Company incorporated a new wholly-owned subsidiary, ApexVest Holdings Limited, in the British Virgin Islands.

On February 2, 2026, the Company entered into an equity investment agreement with Megabyte Solutions Limited (“Megabyte”), securing a 14.28% ownership interest in Megabyte, and for which the Company does not have the ability to exercise significant influence. The investment totaled $3 million.

ITEM 2. - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes that appear elsewhere in this Quarterly Report on Form 10-Q. All share and per-share information presented in this report has been retroactively adjusted to reflect the 1-for-1024 reverse stock split of our common stock, which was effective on ~~October~~December 922, ~~2024~~2025. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth under the heading “Cautionary Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q.

Cautionary Note Regarding Forward-Looking Statements

Some of the information in this document contains, or has incorporated by reference, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements typically are identified by the use of terms such as “may,” “believe,” “anticipate,” “expect,” “plan,” “predict,” “estimate,” “will be,” or other similar words and phrases, although some forward-looking statements are expressed differently. You should be aware that our actual results could differ materially from results anticipated in the forward-looking statements due to a number of factors, including, but not limited to, our ability to effectively operate our business segments, our ability to manage our research, development, expansion, growth, and operating expenses, our ability to evaluate and measure our business, prospects, and performance metrics, our ability to complete, directly and indirectly, and succeed in a highly competitive and evolving industry, our ability to respond and adapt to changes in technology and customer behavior, our ability to protect our intellectual property and to develop, maintain, and enhance a strong brand, and other factors relating to our industry, operations, and results of operations. You should also consider carefully the statements under “Risk Factors,” as disclosed in our ~~Form~~annual report on Form 10-K for the fiscal year ended September 30, 2025, which address additional factors that could cause our actual results to differ from those set forth in the forward-looking statements. Given these uncertainties, current or prospective investors are cautioned not to place undue reliance on any such forward-looking statements. We undertake no obligation to update any such factors or forward-looking statements to reflect future events or developments.

Overview

We are aan ~~building~~innovative technology company that ~~primarily~~engages ~~manufactures~~in ~~cold-formed-steel~~the ~~members~~business ~~and~~of ~~offers~~recycled aconsumer ~~full~~electronic ~~range~~devices. ofWe ~~services~~source ~~required~~and purchase pre-owned toconsumer ~~transform~~electronic ~~raw~~devices ~~materials~~such ~~into~~as ~~precise~~smartphones ~~steel~~and ~~framing~~tablets ~~products~~from suppliers and ~~prefabricated~~sell ~~homes.~~the Weelectronic ~~transform~~devices ~~raw~~to ~~material~~wholesalers ~~(coils~~that ofre-sell these ~~rolled~~products ~~steel of~~to ~~various~~their ~~gauges~~wholesale and/or ~~other~~retail ~~materials)~~customers ~~through~~in ~~our~~Southeast ~~proprietary~~Asia, ~~technologies~~Middle toEast ~~cut~~Asia, ~~punch~~Europe and ~~bend the steel into members or~~ other ~~components~~regions. ~~These~~ ~~work-in-process~~We ~~components~~conduct ~~are~~our business ~~further~~of ~~processed~~recycled ~~into~~consumer ~~finished~~electronic ~~products~~devices ~~which~~through ~~are~~two ~~used~~Hong inKong-based awholly-owned ~~variety~~subsidiaries ofLear ~~building~~Group ~~types,~~Limited ~~including~~and Baymax ~~residential,~~High ~~commercial,~~Technology ~~industrial~~Co., ~~and infrastructure~~Limited.

Since the quarter ended December 31, 2024, we have introduced a new business of electronic products trading. We source and purchase electronic devices, including pre-owned smartphones, tablets, and laptops, from suppliers in Asia, and sell these products to wholesale clients and retail customers in Southeast Asia, Europe and other areas.22

Recent Developments

~~Disposition~~Reverse ofStock ~~Subsidiary~~Split

On ~~April~~December 822, 2025, ~~the~~we ~~Company~~effected ~~entered~~a ~~into~~one-for-twenty-four a(1:24) ~~Share~~reverse ~~Purchase~~stock ~~Agreement~~split ~~with~~of ~~Strucraft~~our ~~Group~~issued ~~Limited,~~and ~~pursuant~~outstanding toshares ~~which~~of common stock (the ~~Company~~“Reverse ~~sold~~Stock ~~all~~Split” or the “Split”). As a result of the Split, every twenty-four (24) shares of common stock issued and outstanding ~~shares~~immediately itprior ~~owns~~to inthe ~~Inno~~effective ~~Disrupts~~date ~~Inc~~was automatically converted into one share of common stock. ~~for~~The Split anwas ~~aggregate~~implemented ~~purchase~~to comply with Nasdaq’s minimum bid price requirement. The Split did not reduce the number of ~~$100~~authorized shares of common stock and did not affect the par value of the common stock.

~~Investment~~At inthe ~~Aurora~~Market ~~Technology Holding Limited~~Offering

On ~~May~~November 2812, 2025, the Company entered into ana ~~equity~~sales ~~investment~~ agreement ~~with~~(the ~~Aurora~~“Sales ~~Technology~~Agreement”) ~~Holding~~with ~~Limited~~Aegis Capital Corp. (the “~~Aurora~~Sales Agent”), ~~securing~~ apursuant ~~16.67%~~to ~~ownership~~which ~~interest~~the inCompany ~~Aurora,~~may offer and ~~for~~sell, ~~which~~from ~~the~~time ~~Company~~to ~~does~~time, ~~not~~to ~~have~~or through the ~~ability~~Sales toAgent, ~~exercise~~shares ~~significant~~of ~~influence.~~the Company’s ~~The~~common ~~investment~~stock, ~~totaled~~with no par value, having an aggregate offering price of up to $150.0 million (the “Placement Shares”).

~~June~~The ~~Securities~~Company ~~Purchase~~is not obligated to sell any Placement Shares under the Sales Agreement. Subject to the terms and conditions of the Sales Agreement, the Sales Agent will use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of The Nasdaq Stock Market LLC (“Nasdaq”), to sell Placement Shares from time to time based upon the Company’s notice and instructions, up to the amount specified therein. Under the Sales Agreement, the Sales Agent may sell Placement Shares by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act of 1933, including sales made directly on Nasdaq or on any other existing trading market or directly to the Sales Agent as principal in negotiated transactions. The Sales Agent may also sell Placement Shares by any other method permitted by law, including in privately negotiated transactions, with the Company’s consent.

OnIn ~~June~~accordance 2,with ~~2025~~the Sales Agreement, the Company ~~entered~~will ~~into~~pay athe ~~securities~~Sales ~~purchase~~Agent ~~agreement~~in ~~with~~cash, ~~certain~~upon ~~investors,~~each sale of Placement Shares pursuant to ~~which~~ the Sales ~~Company~~Agreement, ~~agreed~~an amount equal to ~~issue~~ ~~and~~three ~~sell,~~percent in(3.0%) aof ~~registered~~the ~~direct~~gross ~~offering~~proceeds from each sale of Placement Shares. The Sales Agreement may be terminated by the Company ~~directly~~and the Sales Agent at any time upon notice to the ~~investors~~other ~~(the~~party. ~~“June~~If ~~2025~~not ~~Offering”)~~terminated earlier, anthe ~~aggregate~~Sales ofAgreement ~~1,058,000~~will ~~shares~~automatically (terminate upon the ~~“June~~earlier ~~2025~~to ~~Shares”)~~occur of ~~its~~(i) ~~common~~May ~~stock~~12, no2026 ~~par~~(the ~~value,~~sixth atmonth aanniversary ~~purchase~~of ~~price~~the ~~per~~date ~~share~~ of ~~$0.50. The~~the ~~June~~Sales ~~2025~~Agreement), ~~Offering~~or ~~closed~~(ii) onthe ~~June~~issuance 6,and ~~2025~~sale ~~and~~of all of the ~~Company~~Placement ~~received~~Shares ~~gross~~under ~~proceeds~~the ofSales ~~$529,000~~Agreement.

~~July~~From ~~Standby~~November ~~Equity~~12, ~~Purchase~~2025 to December 31, 2025, the Company issued an aggregate of 3,541,667 shares of common stock (or 85,000,000 shares of common stock before the Reverse Stock Split) for the gross proceeds of approximately $28 million through the Sales Agent pursuant to the Sales Agreement.

OnDecember ~~July~~Securities 4,Purchase 2025, the Company entered into a standby equity purchase agreement (“July SEPA”) with certain investors (each, an “Investor” and collectively, the “Investors”), a copy of which is filed as Exhibit 10.1 to the Company’s Form 8-K filed July 8, 2025. Pursuant to the July SEPA, the Company has the right, but the not the obligation, to issue and sell to those certain investors, from time to time, up to $6 million worth of shares (the “Shares”) of the Company’s common stock, no par value per share. Under the July SEPA, the Company may, at its discretion, issue and sell Shares (“Advance”) to the Investors in accordance with their allocated commitment (“Investor Allocation”) by delivering written notice (“Advance Notice”). Each Advance will be for at least $500,000. An advance to any Investor may not exceed the greater of 9.99% of the outstanding shares of Common Stock held by such Investor, unless otherwise agreed in writing. Any portion of an Advance that would exceed this limitation for any Investor will automatically be withdrawn with no further action required by the Company, and such Advance Notice will be deemed automatically modified to reduce the aggregate amount of the requested Advance by an amount equal to such withdrawn portion for that Investor. In such cases, the Investor will promptly notify the Company of the adjustment.Agreement

~~The~~On ~~July~~December ~~SEPA~~26, ~~will~~2025, ~~automatically terminate on~~ the ~~earlier~~Company ofentered ~~(i)~~into ~~three~~a ~~years~~securities ~~from~~purchase ~~the~~agreement ~~Effective~~with ~~Date~~certain ~~(as~~investors, ~~defined~~pursuant ~~therein)~~to ~~and~~which ~~(ii)~~ the ~~date~~Company agreed onto ~~which~~issue ~~the~~and ~~Investors~~sell, ~~have~~by ~~made~~the ~~payment~~Company ofdirectly ~~Advances equal~~ to ~~their~~the ~~respective~~investors ~~portion of~~ (the ~~Commitment~~“December ~~Amount~~2025 ~~(as~~Offering”), ~~defined~~an ~~therein). The~~aggregate ~~Company~~of ~~has~~3,000,000 shares (the ~~right~~“December to2025 ~~terminate~~Shares”) ~~the~~of ~~July~~its ~~SEPA~~common ~~without~~stock, ~~liability~~no orpar ~~penalty~~value, byat ~~providing~~a ~~five~~purchase ~~trading~~price ~~days’~~per ~~prior~~share ~~written notice~~of to$1.31. ~~the~~The ~~Investors,~~December ~~provided~~2025 Offering ~~that~~closed ~~there~~on ~~are~~January no6, ~~outstanding~~2026 ~~Advance~~and ~~Notices~~the ~~requiring~~Company ~~the~~received ~~issuance~~gross proceeds of ~~Shares~~$3.93 million.

Key Performance Indicators (“KPIs”)

In addition to the measures presented in our consolidated financial statements, our management regularly monitors certain KPIs for our business. The KPIs used by the Company include:

~~The capital turnover rate of raw-material procurement~~23

~~Our~~The ~~business~~turnover israte ~~reliant on timely delivery~~ of ~~raw materials. At the same time, our primary raw material (steel) is expensive to warehouse. We strive to achieve roughly 1-3 months of raw materials~~ inventory to balance our cost of inventory against the risk of not having raw materials when needed. We do this by setting up long-term cooperative relationship with multiple local and national suppliers, including steel mills, in order to obtain a better payment cycle to secure the raw materials and to maximize the use of funds. At the same time, to match the raw-material usage of the sales order each quarter, we make quarterly purchase plans, to ensure the efficiency of capital turnover is higher.

Our business is reliant on timely delivery of our products. At the same time, our products are expensive to warehouse. We strive to achieve roughly 3-6 months of inventory to balance our cost of inventory against the risk of not having products when needed. We do this by setting up long-term cooperative relationship with multiple local and national suppliers to obtain a better payment cycle to secure the products and to maximize the use of funds. At the same time, we maintain a dynamic level of inventories of recycled consumer electronic devices, based on our knowledge of the prevailing market trend and estimation of electronic devices price fluctuation. We continuously adjust our inventory levels by lowering inventory of products in downward trend and increasing inventory of those in upward trend.

The collection period of accounts receivable

Timely payments from customers are essential to a successful business. Based on our historical collectability experience, we will target strategic relationships with large-scale homebuilders and professional companies to reduce the risk associated with accounts receivable and reduce the days outstanding for accounts receivable. Eventually, we expect to achieve the goal of receiving 100% of the payment before products leave the shop.

Lead time

Construction requires the coordination of many contractors, subcontractors, permitting, etc. that must be done on very exacting schedules where any delays will have a ripple effect down the chain. While there are many things we cannot control, we strive to communicate with the customers at a high frequency and make the best production arrangement to minimize storage period and shorten the lead time, which is one of the most important operating indicators of INNO.

The growth of total operating income

We maintain internal long-term targets for both gross profit and operating income, based partly on long-term revenue growth targets and partly on execution and internal controls. Ultimately, we strive to deliver profitable long-term growth.

Results of Operation

The following table presents certain Consolidated statement-of-operations information and presentation of that data as a percentage of change from year to year.

For the Three Months Ended ~~June~~December 3031, 2025, and 2024

	Three Months Ended June 30,
	Three Months Ended December 31,
	2025			2024
Revenues	$	1,~~086~~456,~~250~~481			-196,000		~~100~~643	%
Costs of goods sold		1,~~102~~382,~~300~~346			-180,000		~~100~~668	%
Selling, general and administrative expenses (exclusive of items shown separately below)		1560,~~544,590~~003			~~188~~470,~~667~~592		~~719~~19	%
Operating loss		(1,560,640	)		(188,667	)	727	%
Impairment loss		-			3,514		-100	%
Other income (expenses)		14,352			19,059		-25	%
Operating loss		(485,868	)		(458,106	)	6	%
Loss before income taxes		(1,546,288	)		(169,608	)	812	%
Other income (expenses)		457,250			366		124,832	%
Loss before income taxes		(28,618	)		(457,740	)	-94	%
Income tax expense		-			-		-	%
Net profit/(loss) from discontinued operations		-			(881,273	)	-100	%
Net loss from discontinued operations		-			(147,669	)	-100	%
Net loss		(128,~~546,288~~618	)		(1605,~~050,881~~409	)	47-95	%
Non-controlling interest		-			13(1,~~821~~712	)	-100	%
Net loss attributable to Inno Holdings Inc.	$	(128,~~546,288~~618	)		(1603,~~064,702~~697	)	45-95	%

For the Nine Months Ended June 30, 2025, and 2024

	Nine Months Ended June 30,
	2025			2024
Revenues	$	1,760,350			-		100	%
Costs of goods sold		1,718,900			-		100	%
Selling, general and administrative expenses (exclusive of items shown separately below)		3,425,985			664,665		415	%
Impairment loss		3,514			-		100	%
Operating loss		(3,388,049	)		(664,665	)	410	%
Other income (expenses)		(2,117,120	)		230,091		-1020	%
Loss before income taxes		(5,505,169	)		(434,574	)	1167	%
Income tax expense					800		-100	%
Net profit/(loss) from discontinued operations		(195,796	)		(2,526,698	)	-92	%
Net loss		(5,700,965	)		(2,962,072	)	92	%
Non-controlling interest		69,517			(35,395	)	-296	%
Net loss attributable to Inno Holdings Inc.	$	(5,770,482	)		(2,926,677	)	97	%

Revenues

Revenue for the three months ended ~~June~~December 3031, 2025 increased ~~100~~643% to $1,~~086~~456,~~250~~481 in comparison to $~~Nil~~196,000 for the three months ended ~~June 30~~December 31, 2024. Revenue for the three months ended ~~June~~December 3031, 2025 consists solely of the Company’s ~~new~~ business of electronic products ~~trading that~~ ~~started during this period~~trading. The ~~new~~ business of electronic products trading contributes to the increase in revenue for the three months ended ~~June~~December 3031, 2025 against the comparable period in 2024.

Our revenues are significantly impacted by demand for economic conditions including costs of labor, materials and other variables that impact the cost of our finished goods. We cannot ensure that growth will continue, and our business may be adversely affected by the negative overall economic conditions currently being experienced.

Costs of Goods Sold

Cost of Goods Sold (COGS) includes electronic products purchased from our suppliers. COGS for the three months ended ~~June~~December 3031, 2025, increased to $1,~~102~~382,~~300~~346 in comparison to $~~Nil~~180,000 for the three months ended ~~June~~December 3031, 2024. COGS for the three months ended ~~June~~December 3031, 2025 ~~consists~~ consists solely of electronic products purchased from our suppliers in the Company’s ~~new~~ business of electronic products trading ~~that started during this period~~. The ~~new~~ business of electronic products trading contributes to the increase in COGS for the three months ended ~~June 30~~December 31, 2025 against the comparable period in 2024.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended ~~June~~December 3031, 2025, increased ~~719~~19% to $1560,~~544,590~~003 in comparison to $~~188~~470,~~667~~592 for the comparable period in 2024. The main reason for the increase was due to aan ~~stock~~increase ~~compensation~~in ~~given~~legal toand ~~the~~consulting ~~Company’s employees on May 2025~~expenses.

Operating Loss

Operating loss was $1485,~~560,640~~868 for the three months ended ~~June~~December 3031, 2025, in comparison to an operating loss of $~~188~~458,~~667~~106 for the comparable period in 2024. The increase in operating loss was primarily attributed to the increase in selling, general and administrative expenses, as discussed above.

Other Income (Expense)

Other income for the three months ended ~~June~~December 3031, 2025, was $14457,~~352~~250, in comparison to other income of $~~19,059~~366 for the comparable period in 2024. Other income for the three months ended ~~June~~December 3031, 2025, primarily consisted of a $14370,~~549~~546 change in fair value of SEPA and $86,729 interest income from bank deposits. In contrast, other ~~expenses~~ income for the three months ended ~~June~~December 3031, 2024, were primarily consisted of ~~a loss from a settlement with a subcontractor’s customer, partially offset by a gain from a liability settlement with the landlord and~~ interest income from bank deposits.

Net Loss

Net loss for the three months ended ~~June~~December 3031, 2025 was $128,~~546~~618,~~288,~~ in comparison to net loss of $1605,~~050,881~~409 for the three months ended ~~June~~December 3031, 2024. The increase in net loss was primarily due to changes in revenue, costs and expenses as outlined above.

Liquidity and Capital Resources

Sources of Liquidity

During the three months ended ~~June~~December 3031, 2025 and 2024, we primarily funded our operations with cash generated from operations, private shares ~~offering~~offerings, asand ~~well~~at asthe ~~through~~market ~~borrowing under our revolving line of credit, a long term promissory note, and related parties~~offering. We had cash of $437,~~385~~149,~~289~~913 as of ~~June~~December 3031, 2025 compared to $110,~~077~~130,~~138~~942 of cash as of September 30, ~~2024~~2025. The cash increase was primarily due to the proceeds from the ~~several~~at-the market offering and private-placement ~~offerings~~offering during the quarter ended December 31, ~~2024 and the quarter ended June 30,~~ 2025, and offset by the cash usage in operating and investing activities during the periods ended ~~June 30~~December 31, 2025.

The Company has participated in ~~several~~at-the-market offering and private-placement ~~offerings~~offering during the quarter ended December 31, ~~2024~~2025. On ~~October 31~~November 12, ~~2024~~2025, the Company entered into a ~~securities~~sales ~~purchase~~ agreement (the “Sales Agreement”) with ~~certain~~Aegis ~~investors~~Capital Corp. (the “Sales Agent”), pursuant ~~providing~~to ~~for~~which the ~~sale~~Company may offer and ~~issuance~~sell, offrom ~~500~~time to time,~~000~~ to or through the Sales Agent, shares of the Company’s common stock, with no par value, ~~for~~having an aggregate ~~purchase~~offering price of ~~$2,000,000~~up atto $450.000 ~~per~~million ~~share~~ (the “~~October 2024~~At-the-Market ~~Private Placement~~Offering”). ~~The~~From November ~~offering~~12, ~~closed~~2025 onto ~~November~~December 631, ~~2024~~2025, the Company issued an aggregate of 3,541,667 shares of common stock (or 85,000,000 shares of common stock before the Reverse Stock Split) for the gross proceeds of approximately $28 million through the Sales Agent pursuant to the Sales Agreement.

On November 13, 2024, the Company entered into a securities purchase agreement with nine non-U.S. investors, pursuant to which the Company agreed to issue and sell in a private placement offering (the “November 2024 Private Placement”) an aggregate of 729,167 shares of common stock, no par value, at a purchase price per share of $4.80, for gross proceeds of approximately $3.5 million, of which proceeds will be used for working capital and other general corporate purposes. The offering closed on December 13, 2024.25

On December 1126, ~~2024~~2025, the Company entered into a securities purchase agreement with ~~nine~~certain ~~non-U.S.~~ investors, ~~pursuant~~providing tofor ~~which~~ the ~~Company agreed~~sale ~~to issue~~ and ~~sell in a private placement offering (the “December 2024 Private Placement”) an aggregate~~ issuance of ~~700~~3,000 ,000 shares of the Company’s common stock, no par value, atfor aan aggregate purchase price ~~per share~~ of $23.~~50,~~93 ~~for~~million ~~gross~~at ~~proceeds of approximately~~ $1.7531 ~~million, of which~~per ~~proceeds~~share ~~will~~(the be“December ~~used~~2025 ~~for working capital and other general corporate purposes~~Offering”). The offering closed on ~~December~~January 236, ~~2024~~2026.

OnWe ~~June~~do 2not believe the cash and cash equivalents on hand as of December 31, 2025 of $37,149,913 will be sufficient to fund our operations and capital expenditure requirements for the ~~Company~~next ~~entered~~twelve ~~into~~months afrom ~~securities~~the ~~purchase~~date ~~agreement~~the ~~with~~consolidated ~~certain~~financial ~~investors,~~statements ~~pursuant~~are issued. We will be required to ~~which~~raise ~~the~~additional ~~Company~~capital ~~agreed~~to continue to ~~issue~~ fund operations and ~~sell,~~capital inexpenditure. The uncertainties surrounding our ability to access capital when needed creates substantial doubt about our ability to continue as a ~~registered~~going ~~direct~~concern. ~~offering~~Based byon ~~the~~our ~~Company~~need ~~directly~~to raise additional funds to ~~the~~implement ~~investors~~our (business plans for the ~~“June~~next ~~2025~~twelve ~~Offering”)~~months, anwe ~~aggregate~~have included a discussion concerning the presentation of ~~1,058,000~~our ~~shares~~financial (statements on a going concern basis in the ~~“June~~notes ~~2025~~to ~~Shares”)~~our ofconsolidated ~~its~~financial ~~common~~statements. ~~stock~~We may be required in the near future to issue debt or sell our Company’s equity securities in order to raise additional cash, although there are no ~~par~~firm arrangements ~~value,~~in place for any such financing at athis ~~purchase~~time. ~~price~~We ~~per~~cannot ~~share~~provide any assurances as to whether we will be able to secure the necessary financing, or the terms of $0any such financing transaction if one were to occur.~~50.~~ The failure to secure such financing could ~~June~~severely ~~2025~~curtail ~~Offering~~our ~~closed~~plans onfor ~~June~~future 6,growth ~~2025~~or ~~and~~in ~~the~~more ~~Company~~severe ~~received~~scenarios, ~~gross~~the ~~proceeds~~continued operations of ~~$529,000~~our Company.

We do not believe the cash and cash equivalents on hand as of June 30, 2025 of $4,385,289 will be sufficient to fund our operations and capital expenditure requirements for the next twelve months from the date the consolidated financial statements are issued. We will be required to raise additional capital to continue to fund operations and capital expenditure. The uncertainties surrounding our ability to access capital when needed creates substantial doubt about our ability to continue as a going concern. Based on our need to raise additional funds to implement our business plans for the next twelve months, we have included a discussion concerning the presentation of our financial statements on a going concern basis in the notes to our consolidated financial statements. We will be required in the near future to issue debt or sell our Company’s equity securities in order to raise additional cash, although there are no firm arrangements in place for any such financing at this time. We cannot provide any assurances as to whether we will be able to secure the necessary financing, or the terms of any such financing transaction if one were to occur. The failure to secure such financing could severely curtail our plans for future growth or in more severe scenarios, the continued operations of our Company.

Working Capital

As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, our working capital (deficit) was $644,~~950~~958,~~863~~259 and $~~975~~13,~~755~~337,273, respectively. The historical ~~seasonality~~ seasonality in our business and our capital raising activities during the year can cause cash and cash equivalents, inventory, and accounts ~~payable~~ payable to fluctuate, resulting in changes in our working capital.

Cash Flows

Operating Activities

For the ~~nine~~three months ended ~~June~~December 3031, 2025, net cash used in operating activities was $35,~~704~~001,~~646~~179, primarily driven by the net loss from ~~continuing~~ ~~operation~~continuing ~~of $5,505,169 and net loss from discontinuing~~ operation of $~~265~~28,~~313~~618, ~~partially~~change ~~offset~~in byfair ~~non-cash~~value ~~items~~ of ~~stock-based~~SEPA ~~compensation expense~~ of $2370,~~185~~546,~~205~~ ~~and loss from investment disposal of $2,152,522, and working capital used cash of $1,872,943, which was primarily driven by~~ a $14,~~026~~397,~~834~~904 increase in prepayments and other current assets, an a $285,~~058,800~~591 ~~increase~~decrease in inventories, and a $~~805~~189,~~579~~702 ~~increase~~ decrease in ~~accounts~~other ~~payable,~~payables and ~~operating~~accrued ~~cash flow used by discontinued operations of $398,948~~liabilities.

For the ~~nine~~three months ended ~~June~~December 3031, 2024, net cash used in operating activities was $42,~~861~~096,~~753~~345, primarily driven by the net loss from ~~continuing~~ continuing operation of $~~435~~457,~~374~~740 and net loss from discontinuing operation of $2147,~~491~~669,~~303,~~ ~~partially offset by non-cash items of $83,333 and working capital used cash of $2,905,023, which was primarily driven by~~ a $21,~~775~~893,~~684~~000 increase ofin ~~prepayments and other current assets~~inventories, ~~and~~ a $77757,~~638~~032 decrease inof ~~accounts~~prepayments ~~payable, accounts payable - related party, unearned revenue, operating lease liabilities~~ and other current ~~liabilities~~assets, and operating cash flow used by discontinued operations of $~~886~~421,~~614~~170.

Investing Activities

For the ~~nine~~three months ended ~~June~~December 3031, 2025, net cash used in investing activities was $~~1,522,453 and was primarily the result of investment in equity investee of $1,000,000, which is related to the investment in Aurora Technology Holding Limited~~Nil.

For the ~~nine~~three months ended ~~June~~December 3031, 2024, net cash used in investing activities was $~~412~~1,~~231~~428,154 and was mainly related to the ~~purchase of machinery,~~investment ~~tools,~~in ~~motor~~Core ~~vehicles,~~Modu ~~and leasehold improvements by discontinued operations~~LLC.

Financing Activities

Net cash provided by financing activities was $832,~~535~~020,~~250~~150 and $7,~~157~~250,~~803~~000, respectively, for the ~~nine~~three months ended ~~June~~December 3031, 2025 and 2024.

For the ~~nine~~three months ended ~~June~~December 3031, 2025, net cash provided by financing activities was due to the ~~$8,535,250~~ net cash from the ~~several~~at the market offering and the private-placement ~~offerings~~ offering.

For the ~~nine~~three months ended ~~June~~December 3031, 2024, net cash provided by financing activities was primarily due to the ~~$8,450,000~~ net cash from the ~~initial~~ ~~public offering, offset by $627,000 repayment to related parties and $180,000 payment of short~~several private-~~term~~placement ~~loans and $472,197 used in financing activities by discontinued operations~~offerings.

Critical Accounting Policies and Estimate

The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires us to make judgments, assumptions, and estimates that affect the amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Note 2 — Basis of Presentation and Summary of significant accounting policies in the Notes to the Consolidated Financial Statements included in Part II, Item 8 of our most recently filed Form 10-K, describes the significant accounting policies and methods used in the preparation of the Consolidated Financial Statements. Our critical accounting estimates, identified in Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of our most recently filed Form 10-K, include the discussion of estimates used for revenue recognition, inventory valuation, going concern assessment, and our provision for income taxes. Such accounting estimates require significant judgments and assumptions to be used in the preparation of the Condensed Consolidated Financial Statements included in this Form 10-Q, and actual results could differ materially from the amounts reported.

New Accounting Standards

From time to time, the FASB or other standards-setting bodies issue new accounting pronouncements. Updates to the FASB Accounting Standards Codification are communicated through issuance of an Accounting Standards Update. To understand the impact of recently issued guidance, whether adopted or to be adopted, please review the information provided in Note 2 — Basis of Presentation and Summary of significant accounting policies, “Recently issued but not yet adopted accounting pronouncements”, in the Notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q. Unless otherwise discussed, we believe that the impact of recently issued guidance, whether adopted or to be adopted in the future, is not expected to have a material impact on our Condensed Consolidated Financial Statements upon adoption.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

As a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this item.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

An evaluation was performed under the supervision of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that, as of ~~June~~December 3031, 2025, our disclosure controls and procedures were not effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms due to material weaknesses in our internal controls described below.

● Lack of adequate policies and procedures in internal control function to ensure that proper control and procedures have been designed and implemented over key business cycles. ● Lack of sufficient in-house accounting personnel with the requisite knowledge and experience in the application of U.S. GAAP.

We plan to hire additional personnel or consultant with relevant experience and qualifications to design and implement internal control over key business cycles to strengthen the internal control system, and plan to hire additional in-house accounting personnel with the requisite knowledge and experience in the application of U.S. GAAP. However, we cannot assure you that we will remediate our material weaknesses in a timely manner.

Inherent Limitations Over Internal Controls

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Our control systems are designed to provide such reasonable assurance of achieving their objectives. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Changes in Internal Control over Financial Reporting

There have not been any changes in our internal controls over financial reporting during the ~~period~~quarter ended ~~June~~December 3031, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II

OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

AsWe ofare ~~June~~not ~~30,~~currently ~~2025, the Company is involved in~~ a ~~litigation~~party ~~related~~ to ~~alleged~~any ~~fund~~material ~~transfers.~~legal Aproceedings, ~~plaintiff~~investigations or claims. ~~that~~From ~~one~~time ofto ~~the~~time, ~~Company’s subcontractors~~we ~~misappropriated~~involve ~~over~~in ~~$1.3~~legal ~~million~~matters arising ~~from a construction project~~ in ~~2020-2021, transferring~~ the ~~funds~~ordinary tocourse ~~the company instead~~ of ~~fulfilling~~our ~~a judgment~~business. OnThere ~~July~~can 9,be ~~2025,~~no ~~the~~assurance ~~Company~~that ~~entered~~such ~~into~~matters ~~the~~will ~~Settlement~~not ~~and~~arise ~~Release~~in ~~Agreement with~~ the ~~plaintiff~~future or that ~~for~~any ~~the~~such ~~Settlement~~matters ~~Payment,~~in ~~the~~which ~~plaintiff~~we ~~permanently~~are ~~releases~~involved, ~~acquits,~~or ~~and~~which ~~discharges~~may ~~Inno~~arise ~~Holdings~~in ~~Inc.~~the ~~and~~ordinary ~~its~~course ~~affiliates~~of ~~from~~our ~~all claims~~business, ~~liabilities,~~ ~~and~~will ~~obligations~~not ofat ~~any~~some ~~kind.~~point ~~This~~proceed ~~includes all known and unknown claims up~~ to ~~the Settlement and Release Agreement’s~~litigation ~~effective date, specifically those related to the Lawsuit~~ or ~~any~~that ~~federal,~~such ~~state,~~litigation orwill ~~local~~not ~~laws.~~have ~~The~~a ~~Settlement~~material ~~Payment~~adverse ~~has~~effect ~~been~~on ~~paid to~~our ~~the~~business, ~~plaintiff~~financial oncondition ~~July~~or ~~15,~~results ~~2025~~of operations.

From time to time, we become involved in legal proceedings arising in the ordinary course of our business. We believe that we do not have any threatened litigation which, individually or in the aggregate, would have a material adverse effect on our business, results of operations, financial condition and/or cash flows.

ITEM 1A. RISK FACTORS.

As a “smaller reporting company,” as defined by Rule 12b-2 of the Exchange Act, we are not required to provide the information in this Item. In any event, there have been no material changes in our risk factors as previously disclosed in our ~~2024~~2025 Annual Report on Form 10-K filed with the SEC on December 915, ~~2024~~2025.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

(A) Unregistered Sales of Equity Securities

On ~~October~~December 3126, ~~2024~~2025, the Company entered into a securities purchase agreement with ~~certain~~each of ten non-U.S. investors (the “~~October~~December 2025 ~~2024~~ Investors”) ~~providing~~ ~~for~~pursuant to which the ~~sale~~Company agreed to issue and ~~issuance~~sell in a private placement offering an aggregate of ~~500~~3,000 ,000 shares of ~~the Company’s~~ common stock at a purchase price per share of $1.31, for gross proceeds of approximately $3.9 million (the “~~October~~December 2025 ~~2024 Shares~~Offering”), ~~for an~~of ~~aggregate~~which ~~purchase~~proceeds ~~price~~will ofbe ~~$2,000,000~~used atfor ~~$4.00~~working ~~per~~capital ~~share~~and other general corporate purposes. The ~~offering~~December 2025 Offering closed on ~~November~~January 6, ~~2024~~2026. The issuance and sale of the shares ~~was made~~were exempt from registration under the Securities Act, pursuant to Rule 903 of Regulation S under the ~~exemption~~Securities ~~from~~Act ~~registration~~because ~~provided~~all of the investors were non-U.S. Persons (as defined under Rule 902 Section 4(ak)(2) (i) of ~~the~~Regulation ~~Securities Act~~S).

InThe ~~connection~~foregoing ~~with~~information ~~the~~is ~~October~~a ~~2024~~summary ~~Private~~of ~~Placement,~~our ~~the~~agreements ~~Company~~with ~~entered~~the ~~into~~December a2025 ~~registration~~Investors ~~rights~~involved ~~agreement~~in ~~with~~ the ~~October~~December ~~2024~~2025 ~~Investors, pursuant~~Offering ~~to which~~described above, ~~among~~is ~~other~~not ~~things~~complete, ~~the Company was required to prepare~~ and ~~file~~is ~~with~~qualified ~~the~~in ~~SEC~~its ~~one~~entirety orby ~~more~~reference ~~registration statements~~ to ~~register for~~ the ~~resale~~full text of ~~the~~our ~~shares~~agreement ~~issued~~with ineach ~~the October 2024 Private Placement. On December 27~~investor, ~~2024,~~ the ~~Company~~form of ~~filed~~which ais ~~prospectus supplement~~attached an exhibit to ~~the~~this ~~Registration~~Quarterly ~~Statement~~Report on Form S10-3Q. ~~(File~~Readers ~~No.~~should ~~333-284054)~~review (the ~~“Form~~agreement ~~S-3”),~~for ~~filed~~a ~~with~~complete ~~the SEC on December~~understanding ~~27,~~of ~~2024, registering~~ the ~~October~~terms ~~2024~~and ~~Shares.~~conditions ~~The~~associated ~~Form~~with ~~S-3~~this ~~was declared effective by the SEC on January 10, 2025~~transaction.

On November 13, 2024, the Company entered into a securities purchase agreement with nine non-U.S. investors (the “November 2024 Investors”) pursuant to which the Company agreed to issue and sell in a private placement offering an aggregate of 729,167 shares of common stock (the “November 2024 Shares”) at a purchase price per share of $4.80, for gross proceeds of approximately $3.5 million, of which proceeds will be used for working capital and other general corporate purposes. The November 2024 Private Placement closed in two tranches, with the initial issuance of 277,083 shares on November 20, 2024 and the subsequent issuance of 452,084 shares on December 13, 2024. The issuance and sale of the shares were exempt from registration under the Securities Act, pursuant to Rule 903 of Regulation S under the Securities Act because all of the investors were non-U.S. Persons (as defined under Rule 902 Section (k)(2)(i) of Regulation S).28

In connection with the November 2024 Private Placement, the Company entered into a registration rights agreement with the November 2024 Investors, pursuant to which, among other things, the Company was required to prepare and file with the SEC one or more registration statements to register for the resale of the shares issued in the November 2024 Private Placement. On December 27, 2024, the Company filed a prospectus supplement to the Form S-3, filed with the SEC on December 27, 2024, registering the November 2024 Shares. The Form S-3 was declared effective by the SEC on January 10, 2025.

On December 11, 2024, the Company entered into a securities purchase agreement with nine non-U.S. investors (the “December 2024 Investors”) pursuant to which the Company agreed to issue and sell in a private placement offering an aggregate of 700,000 shares of common stock (the “December 2024 Shares”) at a purchase price per share of $2.50, for gross proceeds of approximately $1.75 million, of which proceeds will be used for working capital and other general corporate purposes. The offering closed on December 23, 2024. The issuance and sale of the shares were exempt from registration under the Securities Act, pursuant to Rule 903 of Regulation S under the Securities Act because all of the investors were non-U.S. Persons (as defined under Rule 902 Section (k)(2)(i) of Regulation S).

In connection with the December 2024 Private Placement, the Company entered into a registration rights agreement with the December 2024 Investors, pursuant to which, among other things, the Company was required to prepare and file with the SEC one or more registration statements to register for the resale of the shares issued in the December 2024 Private Placement. On December 27, 2024, the Company filed a prospectus supplement to the Form S-3 filed with the SEC on December 27, 2024, registering the December 2024 Shares. The Form S-3 was declared effective by the SEC on January 10, 2025.

On June 2, 2025, the Company entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the investors (the “June 2025 Offering”), an aggregate of 1,058,000 shares (the “June 2025 Shares”) of its common stock, no par value, at a purchase price per share of $0.50. The June 2025 Offering closed on June 6, 2025 and the Company received gross proceeds of $529,000. The June 2025 Shares were offered pursuant to a prospectus supplement dated June 4, 2025, filed with the SEC pursuant to Rule 424(b)(5) promulgated under the Securities Act, and the accompanying base prospectus dated December 26, 2024, which together form part of the “shelf” registration statement on Form S-3, which was declared effective by the SEC on January 10, 2025.

On January 27, 2025, the Company entered into a Standby Equity Purchase Agreement (the “January SEPA”) with certain investors effective as of January 28, 2025. Pursuant to January SEPA, the Company has the right to issue and sell to the investors, from time to time, up to $15 million worth of shares of the Company’s common stock, no par value per share, subject to the terms and conditions specified in the January SEPA. On June 20,2025, the Company issued and sold an aggregate of 1,400,000 shares (the “January 2025 SEPA Shares”) of its common stock at a purchase price per share of $0.75, pursuant to January SEPA. The January 2025 SEPA Shares were offered pursuant to a prospectus supplement dated June 17, 2025, filed with the SEC pursuant to Rule 424(b)(5) promulgated under the Securities Act, and the accompanying base prospectus dated December 26, 2024, which together form part of the “shelf” registration statement on Form S-3, which was declared effective by the SEC on January 10, 2025.

(B) Use of Proceeds

Not applicable.

(C) Issuer Purchases of Equity Securities

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

During the quarter ended ~~June~~December 3031, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

ITEM 6. EXHIBITS

EXHIBIT INDEX

		Incorporated by Reference
Exhibit	Description	Schedule/ Form	File Number	Exhibits	Filing Date
10.1	~~Standby~~Sales ~~Equity Purchase~~ Agreement, dated ~~July~~November 812, 2025, by and between Inno Holdings Inc. and ~~the~~Aegis ~~Investors~~Capital Corp.	8-K	001-41882	101.1	~~July~~November 813, 2025
10.2	Form of Securities Purchase Agreement, dated December 26, 2025, by and between Inno Holdings Inc. and certain non-U.S. Person investors	8-K	001-41882	1.1	December 29, 2025
10.3*^	Equity Investment Agreement dated February 2, 2026, by and between Inno Holdings Inc. and Megabyte Solutions Limited
31.1*	Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*		Inline XBRL Instance Document

101.SCH*		Inline XBRL Taxonomy Extension Schema Document

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101).

*	Filed or furnished herewith.
++	Exhibits and Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish a supplemental copy of any such omitted Exhibit or Schedules to the Securities and Exchange Commission upon request.
^	Portions of this exhibit with certain identified and confidential information have been omitted and redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because such information is both not material and would likely cause competitive harm to the registrant if publicly disclosed. The registrant hereby agrees to furnish an unredacted copy of the exhibit and its materiality and competitive harm analyses to the SEC upon request.

2829

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	INNO HOLDINGS, INC.
Date: July 28, 2025	By:	/s/ Ding Wei
Date: February 3, 2026	By:	/s/ Ding Wei
		Ding Wei
		Chief Executive Officer (Principal Executive Officer)
Date: July 28, 2025	By:	/s/ Mengshu Shao
Date: February 3, 2026	By:	/s/ Mengshu Shao
		Mengshu Shao
		Chief Financial Officer (Principal Financial and Accounting Officer)

2930

Filing Compare · INNO HOLDINGS INC.